Processing 00000000.tx.1: Apolipoprotein E Genotypes and the Incidence of Alzheimer's Disease among Persons Aged 75 Years and Older: Variation by Use of Antihypertensive Medication? 

Phrase: "Apolipoprotein E Genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the Incidence of Alzheimer's Disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "among Persons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027361:Persons [Population Group]
   966 E C2347489:Person [Group]
   916 E C1519021:Personal [Organism Attribute]

Phrase: "Aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "75 Years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "Older"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0580836:Old [Temporal Concept]

Phrase: ":"

Phrase: "Variation by Use of Antihypertensive Medication?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.2: Zhenchao Guo, Laura Fratiglioni, Matti Viitanen, Lars Lannfelt, Hans Basun, Johan Fastbom and Bengt Winblad From the Stockholm Gerontology Research Center and Department of Geriatric Medicine, Karolinska Institute, Stockholm, Sweden.  

Phrase: "Zhenchao Guo,"

Phrase: "Laura Fratiglioni,"

Phrase: "Matti Viitanen,"

Phrase: "Lars Lannfelt,"

Phrase: "Hans Basun,"

Phrase: "Johan Fastbom"

Phrase: "and"

Phrase: "Bengt Winblad From the Stockholm Gerontology Research Center"

Phrase: "and"

Phrase: "Department of Geriatric Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C0587471:Geriatric medicine department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "Sweden."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The authors examined the impact of the apolipoprotein E (APOE)*4 allele on Alzheimer's disease incidence in relation to use of antihypertensive medication. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the impact of the apolipoprotein E (APOE)*4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1825598:IMPACT [Gene or Genome]

Phrase: "on Alzheimer's disease incidence"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021149:Incidence [Quantitative Concept]
   827   C0220856:incidence [Functional Concept]
   755 E C1551358:incident [Idea or Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "in relation to"

Phrase: "use of antihypertensive medication."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1524063:Use of [Functional Concept]
   819   C0240320:MEDICATION USE [Finding]
   770   C0003364:Antihypertensive [Pharmacologic Substance]
   770   C0013227:Medication, NOS [Pharmacologic Substance]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]
   770   C3244316:medication [Functional Concept]
Processing 00000000.tx.4: A population-based (Kungsholmen Project) cohort of 985 nondemented Swedish subjects aged 75 years was followed for an average of 3 years (19901992); 

Phrase: "A population-based"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
   861   C1527178:Based [Functional Concept]
   861   C1705938:Based [Idea or Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C0178499:Base [Chemical Viewed Functionally]
   827 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(Kungsholmen Project"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709701:Project [Conceptual Entity]

Phrase: ")"

Phrase: "cohort of 985 nondemented Swedish subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0599755:Cohort [Population Group]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "was"

Phrase: "followed for an average of 3 years"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0332283:followed [Temporal Concept]
   748   C0439234:years [Temporal Concept]
   748   C1510992:Average [Quantitative Concept]
   748   C2825518:AVERAGE [Quantitative Concept]
   714 E C0439508:/year [Temporal Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "(19901992"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.5: 164 dementia (122 Alzheimer's disease) cases were identified. 

Phrase: "164 dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(122 Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.6: Compared with *3/*3, the APOE*4 allele increased the risk of developing dementia (relative risk (RR) = 1.5, 95% confidence interval (CI): 1.1, 2.1) and Alzheimer's disease (RR = 1.7, 95% CI: 1.2, 2.5). 

Phrase: "Compared with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Compared [Activity]

Phrase: "*3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "*3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "the APOE*4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of developing dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "(relative risk (RR)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "= 1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% confidence interval (CI)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "= 1.7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.7: Subjects using antihypertensive medication at baseline (n = 432, 80% used diuretics) had a decreased risk of dementia (RR = 0.6, 95% CI: 0.5, 0.9) and Alzheimer's disease (RR = 0.5, 95% CI: 0.3, 0.8) after adjustment for several variables, including APOE. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication at baseline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003364:Antihypertensive [Pharmacologic Substance]
   770   C0013227:Medication, NOS [Pharmacologic Substance]
   770   C3244316:medication [Functional Concept]

Phrase: "(n = 432,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "80% used diuretics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012798:Diuretics [Pharmacologic Substance]

Phrase: ")"

Phrase: "had"

Phrase: "a decreased risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "= 0.6,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "0.9"

Phrase: ")"

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "= 0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.3,"

Phrase: "0.8"

Phrase: ")"

Phrase: "after"

Phrase: "adjustment for several variables,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0376209:Adjustment [Individual Behavior]
   770   C0456081:Adjustment [Functional Concept]
   770   C0683269:adjustment [Individual Behavior]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "APOE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.8: The effect of antihypertensive medication use was more pronounced among *4 carriers. 

Phrase: "The effect of antihypertensive medication use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1319171:effect medication [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced among"

Phrase: "*4 carriers."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.9: For those not using antihypertensive medication, the relative risks of dementia and Alzheimer's disease for carriers were 2.2 (95% CI: 1.4, 3.4) and 2.3 (95% CI: 1.4, 3.7), respectively. 

Phrase: "For those"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "the relative risks of dementia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0242492:Risks, Relative [Quantitative Concept]
   760   C0035647:Risks [Qualitative Concept]
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease for carriers"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   802   C0560175:disease carrier [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "were"

Phrase: "2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "3.4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442757:3 4 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "2.3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519042:2-3 [Research Activity]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "3.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.10: The corresponding relative risks for those using antihypertensive medication were 0.9 (95% CI: 0.5, 1.6) and 1.1 (95% CI: 0.6, 2.2). 

Phrase: "The corresponding relative risks for those"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0242492:Risks, Relative [Quantitative Concept]
   753   C0035647:Risks [Qualitative Concept]
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "were"

Phrase: "0.9"

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "1.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "1.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.6,"

Phrase: "2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: The APOE*4 allele is an important predictor of dementia and Alzheimer's disease incidence. 

Phrase: "The APOE*4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "an important predictor of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2698872:Predictor [Idea or Concept]

Phrase: "and"

Phrase: "Alzheimer's disease incidence."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021149:Incidence [Quantitative Concept]
   827   C0220856:incidence [Functional Concept]
   755 E C1551358:incident [Idea or Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.12: Further studies are needed to clarify whether use of antihypertensive medication, especially diuretics, modifies the effect of the allele. 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "whether"

Phrase: "use of antihypertensive medication,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   819   C0240320:MEDICATION USE [Finding]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "especially diuretics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012798:Diuretics [Pharmacologic Substance]

Phrase: "modifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the effect of the allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.13: Alzheimer disease; 

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.14: apolipoproteins E; 

Phrase: "apolipoproteins E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003595:Apolipoproteins E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.15: dementia; 

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.16: diuretics; 

Phrase: "diuretics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012798:Diuretics [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.17: genotype; 

Phrase: "genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.18: incidence Abbreviations: APOE, apolipoprotein E genotype; 

Phrase: "incidence Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "APOE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.19: ATC, Anatomical Therapeutic Chemical; 

Phrase: "ATC, Anatomical Therapeutic Chemical"

Phrase: ";"
Processing 00000000.tx.20: CI, confidence interval; 

Phrase: "CI,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: "confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.21: MMSE, Mini-Mental State Examination; 

Phrase: "MMSE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850338:mental state examination [Therapeutic or Preventive Procedure]
   734   C0278060:Mental state [Finding]

Phrase: "Mini-Mental State Examination"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0451306:Mini-mental state examination [Diagnostic Procedure]
   923   C0850338:mental state examination [Therapeutic or Preventive Procedure]
   861   C0278060:Mental state [Finding]
   812   C0229992:mental [Mental Process]
   812   C0445542:Mini [Organism Attribute]
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C3148680:State [Geographic Area]
   729 E C0229993:Psychic [Functional Concept]
   712 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   712 E C0042241:DIAPHRAGM [Medical Device]
   712 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   712 E C1705367:Diaphragm [Medical Device]
   701 E C0086045:mindfulness [Mental Process]
   701 E C3542996:Mindfulness [Mental Process]

Phrase: ";"
Processing 00000000.tx.22: RR, relative risk.  

Phrase: "RR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "relative risk."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.23: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Increasing evidence indicates that the apolipoprotein E (APOE)*4 allele is a major genetic risk factor for late-onset Alzheimer's disease (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(APOE)*4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "a major genetic risk factor for late-onset Alzheimer's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   777   C0814299:factor genetic risk [Qualitative Concept]
   777   C0850664:disease risk factor [Finding]
   760   C0035648:Risk factor [Quantitative Concept]
   757   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   757   C0679238:disease factor [Functional Concept]
   757   C0960756:factor A [Organic Chemical]
   739   C1521761:Factor [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.24: An increased frequency of the *4 allele has consistently been found in both familial and sporadic Alzheimer's disease cases in different ethnic samples (317). 

Phrase: "An increased frequency of the *4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0017270:Allele Frequency [Quantitative Concept]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "has"

Phrase: "consistently"

Phrase: "been"

Phrase: "found in both familial"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0015576:familial [Family Group]
   770   C0150312:Found [Quantitative Concept]
   770   C0241888:Familial [Functional Concept]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "sporadic Alzheimer's disease cases in different ethnic samples"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "(317"

Phrase: ")."
Processing 00000000.tx.25: APOE*4 is related to global cognitive decline in the general elderly population (1821), and it also increases the risk of developing Alzheimer's disease for memory-impaired persons (22, 23). 

Phrase: "APOE*4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "related to global cognitive decline"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   760   C0205246:Global [Spatial Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1516691:Cognitive [Functional Concept]
   760   C2348867:Global [Qualitative Concept]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "in the general elderly population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0683971:General Population [Population Group]
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "(1821"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it also"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of developing Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]

Phrase: "for memory-impaired persons"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0027361:Persons [Population Group]
   793 E C2347489:Person [Group]
   743 E C1519021:Personal [Organism Attribute]
   734   C0233794:MEMORY IMPAIRED [Mental or Behavioral Dysfunction]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.26: A community-based prospective study has provided strong evidence supporting the APOE*4 allele as a risk factor for Alzheimer's disease, but it also suggested that previous family and case-control studies may have overestimated the contribution (24). 

Phrase: "A community-based prospective study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033522:prospective study [Research Activity]
   861   C1709709:Prospective Study [Research Activity]
   812   C0023981:prospective [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "provided strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the APOE*4 allele as a risk factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   742   C0002085:Allele [Gene or Genome]

Phrase: "for Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "but"

Phrase: "it also"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that previous family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "case-control studies"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0007328:Case-Control Studies [Research Activity]
   913   C0085973:Case Studies [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0868928:Case [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "have"

Phrase: "overestimated"

Phrase: "the contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribution [Activity]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.27: Indeed, *4 alone is neither necessary nor sufficient for development of the disease (11); 

Phrase: "Indeed,"

Phrase: "*4 alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "neither necessary"

Phrase: "nor"

Phrase: "sufficient for development of the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205410:Sufficient [Qualitative Concept]

Phrase: "(11"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.28: a considerable proportion of *4 carriers do escape the disease (9). 

Phrase: "a considerable proportion of *4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0007294:carriers [Finding]
   771 E C0560175:Carrier [Finding]
   771 E C1706209:Carrier [Medical Device]
   771 E C3273162:Carrier [Intellectual Product]

Phrase: "do"

Phrase: "escape"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870509:escape [Mental Process]
  1000   C1880554:ESCAPE [Event]

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.29: Several studies have also noted a lack of significant association between *4 and Alzheimer's disease (25, 26). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "a lack of significant association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "between"

Phrase: "*4"

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.30: A recent study (27) found evidence supporting a previous view that the APOE*4 allele is not a significant risk factor for Alzheimer's disease among African Americans and Hispanics. 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(27"

Phrase: ")"

Phrase: "found evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a previous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Previous [Temporal Concept]
  1000   C1552607:previous [Temporal Concept]

Phrase: "view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that"

Phrase: "the APOE*4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a significant risk factor for Alzheimer's disease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "among African Americans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085756:African Americans [Population Group]
   861   C0027567:African [Population Group]
   861   C0596070:americans [Population Group]

Phrase: "and"

Phrase: "Hispanics."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0086409:Hispanics [Population Group]
   966 E C0019576:Hispanic [Population Group]
Processing 00000000.tx.31: It has been argued that the effect of APOE*4 may be mediated by other genetic factors or may be modified by some environmental exposures (28, 29). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "argued"

Phrase: "that"

Phrase: "the effect of APOE*4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "mediated by other genetic factors"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0314603:Genetic [Functional Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "or"

Phrase: "may"

Phrase: "be"

Phrase: "modified by some environmental exposures"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0014412:Exposures, Environmental [Injury or Poisoning]
   806   C0205349:Modified By [Qualitative Concept]
   760   C0014406:Environmental [Spatial Concept]
   760   C0274281:exposures [Injury or Poisoning]
   760   C0392747:Modified [Functional Concept]
   760   C0728853:exposures [Phenomenon or Process]
   726 E C0332157:Exposure [Clinical Attribute]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.32: The Kungsholmen Project is a community-based longitudinal study of aging and dementia in people aged 75 years and older (30). 

Phrase: "The Kungsholmen Project"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709701:Project [Conceptual Entity]

Phrase: "is"

Phrase: "a community-based longitudinal study of aging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0023981:Longitudinal Study [Research Activity]
   748   C0205127:Longitudinal [Spatial Concept]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "dementia in people"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "older"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0580836:Old [Temporal Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.33: In our previous analysis, we found that use of antihypertensive medication (80 percent diuretics) was related to a lower prevalence of dementia, a decreased risk of developing dementia, and a slower cognitive decline among patients with dementia (31). 

Phrase: "In our previous analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that use of antihypertensive medication"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1524063:Use of [Functional Concept]
   797   C0240320:MEDICATION USE [Finding]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "(80 percent diuretics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012798:Diuretics [Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "related to a lower prevalence of dementia,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0033105:Prevalence [Quantitative Concept]
   748   C0220900:prevalence [Quantitative Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C0445223:Related [Finding]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "a decreased risk of developing dementia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "a slower cognitive decline among patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.34: We therefore examined the effect of the APOE*4 allele on the incidence of dementia and Alzheimer's disease by considering use of these drugs.  

Phrase: "We therefore"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of the APOE*4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on the incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "Alzheimer's disease by considering use of these drugs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.35: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Study population The study population consisted of 1,310 subjects who were free of dementia at baseline and who participated in the first follow-up of the Kungsholmen Project. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES  Study population"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   858   C0683954:results study [Finding]
   827   C2348561:Study Population [Population Group]
   799   C0032659:Population [Quantitative Concept]
   799   C0557651:Study [Manufactured Object]
   799   C1257890:Population [Population Group]
   799   C2603343:Study [Research Activity]

Phrase: "The study population"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2348561:Study Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C0557651:Study [Manufactured Object]
   861   C1257890:Population [Population Group]
   861   C2603343:Study [Research Activity]

Phrase: "consisted of 1,310 subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   726   C0332529:CONSIST [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "were"

Phrase: "free of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332296:free [Functional Concept]
   790   C1880497:Free [Qualitative Concept]
   790   C1996904:Free [Qualitative Concept]

Phrase: "at baseline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]

Phrase: "and"

Phrase: "who"

Phrase: "participated in the first follow-up of the Kungsholmen Project."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0589120:Follow-up [Finding]
   760   C1522577:follow-up [Health Care Activity]
   760   C1704685:FOLLOW-UP [Intellectual Product]
   760   C3274571:FOLLOW-UP [Health Care Activity]
   739   C0205435:First [Quantitative Concept]
   739   C0332283:follow [Temporal Concept]
   739   C1279901:First [Qualitative Concept]
   739   C1709701:Project [Conceptual Entity]
   739   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.36: Of these subjects, 985 with APOE genotyping were included in this analysis. 

Phrase: "Of these subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "985 with APOE genotyping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1285573:Genotyping [Laboratory Procedure]

Phrase: "were"

Phrase: "included in this analysis."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332257:included [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.37: The Kungsholmen Project is a longitudinal study of aging and dementia that targeted all inhabitants of the Kungsholmen district of Stockholm, Sweden, who were aged 75 years and older on October 1, 1987 (30). 

Phrase: "The Kungsholmen Project"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709701:Project [Conceptual Entity]

Phrase: "is"

Phrase: "a longitudinal study of aging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0023981:Longitudinal Study [Research Activity]
   760   C0205127:Longitudinal [Spatial Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "that"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "all inhabitants of the Kungsholmen district of Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "who"

Phrase: "were"

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "older on October 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0580836:Old [Temporal Concept]

Phrase: "1987"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.38: To detect prevalent cases of dementia at baseline, the Mini-Mental State Examination (MMSE) was administered to 1,810 participants (32). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "prevalent cases of dementia"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "at baseline,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]

Phrase: "the Mini-Mental State Examination (MMSE)"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0451306:Mini-mental state examination [Diagnostic Procedure]
   923   C0850338:mental state examination [Therapeutic or Preventive Procedure]
   861   C0278060:Mental state [Finding]
   812   C0229992:mental [Mental Process]
   812   C0445542:Mini [Organism Attribute]
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C3148680:State [Geographic Area]
   729 E C0229993:Psychic [Functional Concept]
   712 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   712 E C0042241:DIAPHRAGM [Medical Device]
   712 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   712 E C1705367:Diaphragm [Medical Device]
   701 E C0086045:mindfulness [Mental Process]
   701 E C3542996:Mindfulness [Mental Process]

Phrase: "was"

Phrase: "administered to 1,810 participants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0679646:participants [Population Group]
   760   C1521801:Administered [Functional Concept]
   726 E C1621583:Administer [Functional Concept]
   726 E C2698741:Participant [Classification]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.39: Those with an MMSE score of <24 (n = 314) and a random sample of subjects with an MMSE score of 24 (n = 354) were then examined clinically (33). 

Phrase: "Those with an MMSE score of <24"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   845   C0850338:mental state examination [Therapeutic or Preventive Procedure]
   818   C0278060:Mental state [Finding]
   795   C0229992:mental [Mental Process]
   795   C0332287:With [Qualitative Concept]
   795   C0449820:Score [Quantitative Concept]
   795   C1301808:State [Geographic Area]
   795   C1442792:State [Functional Concept]
   795   C1705690:With [Intellectual Product]
   795   C3148680:State [Geographic Area]
   712 E C0229993:Psychic [Functional Concept]

Phrase: "(n = 314"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "a random sample of subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0150105:random sample [Research Activity]
   760   C0034656:RANDOM [Research Activity]
   760   C0370003:Sample [Substance]
   760   C0439605:Random [Qualitative Concept]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "with an MMSE score"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449820:Score [Quantitative Concept]
   756   C0850338:mental state examination [Therapeutic or Preventive Procedure]

Phrase: "of 24"

Phrase: "(n = 354"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "clinically"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.40: Of 1,475 baseline participants who were free of dementia as diagnosed by means of the two-phase design, 174 were excluded from further follow-up because they refused to participate or moved away from Stockholm. 

Phrase: "Of 1,475 baseline participants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0679646:participants [Population Group]
   779 E C2698741:Participant [Classification]

Phrase: "who"

Phrase: "were"

Phrase: "free of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332296:free [Functional Concept]
   790   C1880497:Free [Qualitative Concept]
   790   C1996904:Free [Qualitative Concept]

Phrase: "as"

Phrase: "diagnosed by means of the two-phase design,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   744   C0011900:Diagnosed [Finding]
   744   C0205390:Phase [Temporal Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C1704970:Means [Conceptual Entity]
   744   C1707689:Design [Activity]
   744   C2983265:DESIGN [Intellectual Product]
   711 E C0444504:Mean [Quantitative Concept]
   711 E C2347634:Mean [Quantitative Concept]
   711 E C2348143:Mean [Quantitative Concept]

Phrase: "174"

Phrase: "were"

Phrase: "excluded from further follow-up"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0589120:Follow-up [Finding]
   806   C1522577:follow-up [Health Care Activity]
   806   C1704685:FOLLOW-UP [Intellectual Product]
   806   C3274571:FOLLOW-UP [Health Care Activity]
   760   C0332283:follow [Temporal Concept]
   760   C1517331:Further [Spatial Concept]
   760   C1554077:Excluded [Idea or Concept]
   760   C1719822:Follow [Intellectual Product]
   760   C2828389:Excluded [Activity]
   726 E C0205108:far [Spatial Concept]
   726 E C0332196:Exclude [Functional Concept]

Phrase: "because"

Phrase: "they"

Phrase: "refused"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1548564:Refused [Idea or Concept]
  1000   C1705116:Refused [Activity]
   966 E C0017095:Refuse [Environmental Effect of Humans]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate"

Phrase: "or"

Phrase: "moved away from Stockholm."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0421433:Moved away [Finding]
   819   C1269909:Moved from [Functional Concept]
           moved
   770   C1299988:moved [Functional Concept]
   770   C2699029:Moved [Activity]
   737 E C0560560:move [Organism Function]
   737 E C0578671:move [Finding]
Processing 00000000.tx.41: Thus, 1,301 subjects remained for the follow-up assessment of incident dementia cases; 

Phrase: "Thus,"

Phrase: "1,301 subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "remained for the follow-up assessment of incident dementia cases"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   777   C1579934:Assessment of dementia [Health Care Activity]
           Dementia assessment
   760   C0589120:Follow-up [Finding]
   760   C1522577:follow-up [Health Care Activity]
   760   C1704685:FOLLOW-UP [Intellectual Product]
   760   C3274571:FOLLOW-UP [Health Care Activity]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0332283:follow [Temporal Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0868928:Cases [Functional Concept]
   739   C1261322:Assessment [Health Care Activity]
   739   C1516048:Assessment [Activity]
   739   C1533148:Cases [Quantitative Concept]
   739   C1551358:incident [Idea or Concept]
   739   C1719822:Follow [Intellectual Product]
   706 E C1706255:CASE [Medical Device]
   706 E C1706256:Case [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.42: of these 1,301 subjects, 985 agreed to provide a blood sample for APOE genotyping. 

Phrase: "of these 1,301 subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "985"

Phrase: "agreed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3641827:Agree [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a blood sample for APOE genotyping."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0178913:Blood sample [Body Substance]
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.43: Identification of dementia Of the 985 subjects who provided a blood sample, 840 were administered a comprehensive clinical examination between November 1990 and April 1992. 

Phrase: "Identification of dementia Of the 985 subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "who"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "a blood sample,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:Blood sample [Body Substance]
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "840"

Phrase: "were"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "a comprehensive clinical examination between November 1990"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0031809:Clinical examination [Health Care Activity]
   748   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "April 1992."
Processing 00000000.tx.44: A total of 145 subjects died before the follow-up examination; 

Phrase: "A total of 145 subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "died before the follow-up examination"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0260832:Follow-up examination [Finding]
   790   C0589120:Follow-up [Finding]
   790   C1522577:follow-up [Health Care Activity]
   790   C1704685:FOLLOW-UP [Intellectual Product]
   790   C3274571:FOLLOW-UP [Health Care Activity]
   753   C0011065:Died [Organism Function]
   753   C0332283:follow [Temporal Concept]
   753   C1546956:Died [Finding]
   753   C1719822:Follow [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.45: the medical records and death certificates of these subjects were reviewed by physicians. 

Phrase: "the medical records"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0025102:Medical Records [Intellectual Product]
  1000   C0551625:Medical records [Clinical Attribute]
  1000   C1554096:Medical records [Intellectual Product]
   861   C0034869:Records [Intellectual Product]
   861   C0205476:Medical [Functional Concept]
   861   C1548330:Records [Idea or Concept]
   861   C1553414:Records [Qualitative Concept]

Phrase: "and"

Phrase: "death certificates of these subjects"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0011066:Death Certificates [Intellectual Product,Manufactured Object]
   760   C0011065:Death [Organism Function]
   760   C0586303:Certificates [Intellectual Product]
   760   C1306577:Death, NOS [Finding]
   753 E C0586268:Death certification [Health Care Activity]

Phrase: "were"

Phrase: "reviewed by physicians."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0031831:Physicians [Professional or Occupational Group]
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C0804815:Physician [Clinical Attribute]
   756 E C1552617:Review [Idea or Concept]
Processing 00000000.tx.46: Diagnostic and Statistical Manual of Mental Disorders, third edition, revised, diagnostic criteria (34) were used to define dementia. 

Phrase: "Diagnostic and Statistical Manual of Mental Disorders,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C1136324:Diagnostic and Statistical Manual of Mental Disorders [Intellectual Product]
   877   C0599833:Diagnostic and Statistical Manual [Intellectual Product]
   818   C0004936:Mental disorders [Mental or Behavioral Dysfunction]
   795   C0011900:Diagnostic [Finding]
   795   C0012634:Disorders [Disease or Syndrome]
   795   C0024763:Manual [Intellectual Product,Manufactured Object]
   795   C0038215:Statistical [Occupation or Discipline]
   795   C0175674:Manual [Functional Concept]
   795   C0229992:mental [Mental Process]
   795   C0348026:Diagnostic [Functional Concept]
   785 E C0033975:mental disorder [Mental or Behavioral Dysfunction]
   768 E C0152097:diaphragm disorders [Disease or Syndrome]
   760 E C0277577:PSYCHIC DISORDER [Mental or Behavioral Dysfunction]
   712 E C0229993:Psychic [Functional Concept]

Phrase: "third edition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441796:Third edition [Intellectual Product]
   861   C0441792:Edition [Intellectual Product]

Phrase: "revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: ","

Phrase: "diagnostic criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679228:diagnostic criteria [Intellectual Product]
   861   C0243161:criteria [Intellectual Product]

Phrase: "(34"

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.47: A diagnosis of Alzheimer's disease requires gradual onset, progressive deterioration, and lack of specific causes of dementia. 

Phrase: "A diagnosis of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "requires"

Phrase: "gradual onset,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332164:Gradual onset [Qualitative Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "progressive deterioration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0868945:Deterioration [Phenomenon or Process]

Phrase: "and"

Phrase: "lack of specific causes of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]
Processing 00000000.tx.48: Our criteria for identifying Alzheimer's disease were similar to those used by the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) (35) for probable Alzheimer's disease. 

Phrase: "Our criteria for identifying Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:criteria [Intellectual Product]

Phrase: "were"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "by the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   860   C0027765:neurological disease [Disease or Syndrome]
   801   C0002395:Alzheimer's Disease [Disease or Syndrome]
   801   C1521724:Alzheimer's Disease [Pathologic Function]
   788   C0012634:Disease [Disease or Syndrome]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Related Disorders Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(NINCDS-ADRDA"

Phrase: ")"

Phrase: "(35"

Phrase: ")"

Phrase: "for probable Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.49: Three steps were used for diagnosis. 

Phrase: "Three steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "were"

Phrase: "used for diagnosis."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0011900:Diagnosis [Finding]
   790   C1273517:used [Finding]
   790   C1704338:diagnosis [Qualitative Concept]
   790   C1704656:DIAGNOSIS [Research Activity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.50: First, the examining physician made a preliminary diagnosis. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the examining physician"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031831:Physician [Professional or Occupational Group]
   861   C0804815:Physician [Clinical Attribute]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "a preliminary diagnosis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0332134:Preliminary diagnosis [Qualitative Concept]
  1000   C1716046:Preliminary diagnosis [Clinical Attribute]
   861   C0011900:Diagnosis [Finding]
   861   C0439611:Preliminary [Temporal Concept]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.51: Second, all cases were reviewed independently by a neurologist, and a second preliminary diagnosis was made. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "independently by a neurologist,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0237426:Neurologist [Professional or Occupational Group]

Phrase: "and"

Phrase: "a second preliminary diagnosis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0332134:Preliminary diagnosis [Qualitative Concept]
   901   C1716046:Preliminary diagnosis [Clinical Attribute]
   877   C0332138:Secondary diagnosis [Qualitative Concept]
   827   C0011900:Diagnosis [Finding]
   827   C0439611:Preliminary [Temporal Concept]
   827   C1704338:diagnosis [Qualitative Concept]
   827   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "made."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]
Processing 00000000.tx.52: In the event of agreement between the first and second diagnoses, this second diagnosis was considered final; 

Phrase: "In the event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "of agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "between the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "second diagnoses,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   947   C0332138:Secondary diagnosis [Qualitative Concept]
   861   C0011900:Diagnoses [Finding]
   827 E C1704338:diagnosis [Qualitative Concept]
   827 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "this second diagnosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   964   C0332138:Secondary diagnosis [Qualitative Concept]
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "final"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205088:Final [Temporal Concept]
  1000   C1546485:Final [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.53: in the event of disagreement, a third opinion was requested and the concordant diagnosis was accepted. 

Phrase: "in the event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "of disagreement,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680238:Disagreement [Social Behavior]

Phrase: "a third opinion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871010:opinion [Mental Process]

Phrase: "was"

Phrase: "requested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1272683:Requested [Functional Concept]
   966 E C0686900:request [Functional Concept]
   966 E C1522634:Request [Intellectual Product]

Phrase: "and"

Phrase: "the concordant diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "accepted."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.54: Details of the clinical examination, diagnostic procedure, and primary results of data on the age- and sex-specific incidence of dementia have been presented elsewhere (36). 

Phrase: "Details of the clinical examination,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0939974:Detail of examination [Functional Concept]
   760   C1522508:Details [Qualitative Concept]
   726 E C1561567:detail [Functional Concept]

Phrase: "diagnostic procedure,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0430022:diagnostic procedure [Diagnostic Procedure]
  1000   C1546908:Diagnostic procedure [Functional Concept]
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "primary results of data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "on the age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex-specific incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "elsewhere"

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.55: Data collection The baseline examination was conducted from October 1987 to December 1989. 

Phrase: "Data collection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0010995:Data Collection [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   861   C3245479:data [Medical Device]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "The baseline examination"

Phrase: "was"

Phrase: "conducted from October 1987"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0004927:Conduct [Individual Behavior]

Phrase: "to December 1989."
Processing 00000000.tx.56: Arterial blood pressure was measured by using a mercury sphygmomanometer, with the subject in a seated position after a 5-minute rest (37). 

Phrase: "Arterial blood pressure"
Meta Candidates (Total=24; Excluded=7; Pruned=0; Remaining=17)
  1000   C1272641:Blood Pressure, Arterial [Finding]
           Arterial Pressure
           Blood pressure
   913   C0232108:Arterial pressure [Organ or Tissue Function]
   901   C0005823:Blood Pressure [Organism Function]
   901   C0229665:Arterial blood [Tissue]
   901   C1271104:Blood Pressure [Finding]
   901   C1550611:Arterial Blood [Body Substance]
   901   C2335890:Arterial blood [Tissue]
   827   C0003842:Arterial [Body Part, Organ, or Organ Component]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0221464:Arterial [Spatial Concept]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mercury sphygmomanometer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183432:Mercury sphygmomanometer [Medical Device]
   861   C0183427:Sphygmomanometer [Medical Device]

Phrase: "with the subject"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "in a seated position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "after a 5-minute rest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035253:Rest [Daily or Recreational Activity]
   827   C1622890:ResT [Molecular Function]
   734   C0886384:5 minute [Therapeutic or Preventive Procedure]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.57: A standard polymerase chain reaction procedure was used for APOE genotyping (38, 39), and the DNA was prepared from peripheral blood samples. 

Phrase: "A standard polymerase chain reaction procedure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   804   C1948041:Procedure [Therapeutic or Preventive Procedure]
   804   C2700391:Procedure [Activity]
   804   C3274430:PROCEDURE [Health Care Activity]
   804   C3538935:Procedure [Idea or Concept]
   804   C3539779:Procedure [Intellectual Product]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "used for APOE genotyping"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1273517:used [Finding]
   760   C1285573:Genotyping [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "(38,"

Phrase: "39"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared from peripheral blood samples."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0178913:blood samples [Body Substance]
   806   C0229664:peripheral blood [Body Substance]
           Blood
   765 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0205100:Peripheral [Spatial Concept]
   726   C0370003:Sample [Substance]
   726   C1521827:Prepare [Functional Concept]
   726   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.58: Information regarding the medical history of each participant was derived from the computerized inpatient register, which covers all hospitals in the Stockholm area. 

Phrase: "Information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "regarding"

Phrase: "the medical history of each participant"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0262926:Medical History [Finding]
           History
   790   C1704706:Medical History [Idea or Concept]
   753   C0019664:History [Occupation or Discipline]
   753   C0019665:history [Intellectual Product]
   753   C0205476:Medical [Functional Concept]
   753   C0262512:History, NOS [Organism Attribute]
   753   C1705255:History [Conceptual Entity]
   753   C2004062:History [Finding]

Phrase: "was"

Phrase: "derived from the computerized inpatient register,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021562:inpatient [Patient or Disabled Group]
   753   C1441547:Derived [Qualitative Concept]
   753   C1548438:Inpatient [Idea or Concept]
   753   C1549404:Inpatient [Idea or Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "which"

Phrase: "covers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0180153:cover [Medical Device]
  1000   C1707529:Cover [Medical Device]
  1000   C1999244:Cover [Functional Concept]

Phrase: "all hospitals in the Stockholm area."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0019994:Hospitals [Health Care Related Organization,Manufactured Object]
   753   C1609061:Hospitals [Intellectual Product]
   719 E C1510665:Hospital [Qualitative Concept]
Processing 00000000.tx.59: Heart disease (myocardial infarction, cardiac dysrhythmia, and heart failure) and stroke were treated as two potential confounders. 

Phrase: "Heart disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018799:Heart disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(myocardial infarction,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0027051:Myocardial Infarction [Disease or Syndrome]
  1000   C0428953:MYOCARDIAL INFARCTION [Finding]
  1000   C2926063:Myocardial infarction [Clinical Attribute]
   861   C0021308:Infarction [Pathologic Function]
   861   C0027061:Myocardial [Tissue]
   861   C1522564:Myocardial [Spatial Concept]
   789 E C0333541:Infarcted [Functional Concept]

Phrase: "cardiac dysrhythmia,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003811:Cardiac Dysrhythmia [Pathologic Function]
           dysrhythmia
   861   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   861   C1522601:Cardiac [Spatial Concept]

Phrase: "and"

Phrase: "heart failure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0018801:Heart failure [Disease or Syndrome]
  1000   C0018802:Heart Failure [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "stroke"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "were"

Phrase: "treated as two potential confounders."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205448:Two [Quantitative Concept]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C3245505:Potential [Qualitative Concept]
   726 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.60: Information on drug use, both prescription and nonprescription, was collected for the 2 weeks preceding the baseline interview (40, 41), and drug containers and prescription forms were inspected to verify the information. 

Phrase: "Information on drug use,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1456676:Drug Information [Intellectual Product]
   770   C1533716:Information [Idea or Concept]

Phrase: "both prescription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033080:Prescription [Health Care Activity]
  1000   C1521941:Prescription [Intellectual Product]

Phrase: "and"

Phrase: "nonprescription,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013231:Nonprescription [Pharmacologic Substance]

Phrase: "was"

Phrase: "collected for the 2 weeks"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0439230:weeks [Temporal Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "the baseline interview"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021822:Interview [Activity]
   861   C0935630:Interview [Intellectual Product]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "drug containers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013166:Drug Containers [Manufactured Object]
   861   C0180098:Containers [Manufactured Object]

Phrase: "and"

Phrase: "prescription forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "inspected"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the information."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]
Processing 00000000.tx.61: Antihypertensive drugs included all medicines potentially used to lower blood pressure (Anatomical Therapeutic Chemical (ATC) classification system (42) codes C02, C03, and C07). 

Phrase: "Antihypertensive drugs"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0003364:Anti-Hypertensive Drugs [Pharmacologic Substance]
           Antihypertensive
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "all medicines potentially"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013227:Medicines [Pharmacologic Substance]
   827 E C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "(Anatomical Therapeutic Chemical (ATC) classification system"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   840   C0008902:Classification system [Classification]
           Classification
   804   C0008903:classification [Functional Concept]
   804   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   804   C0220784:Anatomical [Qualitative Concept]
   804   C0220806:Chemical [Chemical]
   804   C0302350:Therapeutic [Functional Concept]
   804   C0449913:System [Functional Concept]
   804   C0678229:classification [Occupational Activity]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   804   C3272558:Chemical [Intellectual Product]
   733 E C0002808:Anatomies [Biomedical Occupation or Discipline]
   733 E C0205373:Systemic [Functional Concept]
   733 E C0700276:anatomy [Anatomical Structure]
   733 E C1384516:anatomy [Qualitative Concept]

Phrase: "(42"

Phrase: ")"

Phrase: "codes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009219:code [Occupational Activity]
  1000   C0805701:Code [Intellectual Product]
  1000   C0919279:codes [Classification]

Phrase: "C02,"

Phrase: "C03,"

Phrase: "and"

Phrase: "C07"

Phrase: ")."
Processing 00000000.tx.62: For analysis, we first divided the whole sample into two groups according to use of antihypertensive medication. 

Phrase: "For analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "divided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:Divided [Functional Concept]

Phrase: "the whole sample into two groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "according to use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of antihypertensive medication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]
Processing 00000000.tx.63: We then divided the whole sample into two groups by use of diuretics (ATC code C03), regardless of other antihypertensive medication. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "divided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:Divided [Functional Concept]

Phrase: "the whole sample into two groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of diuretics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012798:Diuretics [Pharmacologic Substance]

Phrase: "(ATC code C03"

Phrase: ")"

Phrase: ","

Phrase: "regardless of other antihypertensive medication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]
Processing 00000000.tx.64: Finally, the sample was divided into three groups: the group receiving diuretic monotherapy, the group using other antihypertensive medications (ATC codes C02 and C07), and the group not using antihypertensive medications. 

Phrase: "Finally,"

Phrase: "the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "divided into three groups"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0205449:Three [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "diuretic monotherapy,"

Phrase: "the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "other antihypertensive medications"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medications [Pharmacologic Substance]
   861   C0802604:Medications [Clinical Attribute]
   861   C2598133:Medications [Clinical Attribute]
   827 E C3244316:medication [Functional Concept]

Phrase: "(ATC codes C02"

Phrase: "and"

Phrase: "C07"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medications."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medications [Pharmacologic Substance]
   861   C0802604:Medications [Clinical Attribute]
   861   C2598133:Medications [Clinical Attribute]
   827 E C3244316:medication [Functional Concept]
Processing 00000000.tx.65: Among those who participated in the first follow-up of the Kungsholmen Project (n = 1,310), the drugs used by more than 20 subjects at baseline included diuretics (bendroflumethiazide, hydrochlorothiazide, furosemide, spironolactone, amiloride hydrochloride), calcium channel antagonists (verapamil, nifedipine, diltiazem), and -blockers (metoprolol tartrate, propranolol hydrochloride, alprenolol hydrochloride, atenolol). 

Phrase: "Among those"

Phrase: "who"

Phrase: "participated in the first follow-up of the Kungsholmen Project"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0589120:Follow-up [Finding]
   760   C1522577:follow-up [Health Care Activity]
   760   C1704685:FOLLOW-UP [Intellectual Product]
   760   C3274571:FOLLOW-UP [Health Care Activity]
   739   C0205435:First [Quantitative Concept]
   739   C0332283:follow [Temporal Concept]
   739   C1279901:First [Qualitative Concept]
   739   C1709701:Project [Conceptual Entity]
   739   C1719822:Follow [Intellectual Product]

Phrase: "(n = 1,310"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441922:N+ [Intellectual Product]
   827   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "used by more"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   882   C1273517:Used by [Finding]
           used
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "than 20 subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "at baseline included diuretics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012798:Diuretics [Pharmacologic Substance]

Phrase: "(bendroflumethiazide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004975:Bendroflumethiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0701080:Naturetin [Organic Chemical,Pharmacologic Substance]

Phrase: "hydrochlorothiazide,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "furosemide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016860:Furosemide [Organic Chemical,Pharmacologic Substance]
   944 E C0699992:Lasix [Organic Chemical,Pharmacologic Substance]

Phrase: "spironolactone,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037982:Spironolactone [Pharmacologic Substance,Steroid]
   944 E C0591054:Aldactone [Pharmacologic Substance,Steroid]

Phrase: "amiloride hydrochloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0546849:Amiloride Hydrochloride [Organic Chemical,Pharmacologic Substance]
   861   C0002502:Amiloride [Organic Chemical,Pharmacologic Substance]
   861   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "calcium channel antagonists"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C2757014:Calcium Channel Antagonists [Molecular Function]
   901   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C0006684:calcium antagonist [Pharmacologic Substance]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0243076:antagonists [Chemical Viewed Functionally]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
   827   C2936886:Calcium [Pharmacologic Substance]
   793 E C0231491:Antagonist [Organ or Tissue Function]
   721 E C0680242:antagonism [Social Behavior]

Phrase: "(verapamil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042523:Verapamil [Organic Chemical,Pharmacologic Substance]

Phrase: "nifedipine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "diltiazem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012373:Diltiazem [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "blockers"

Phrase: "(metoprolol tartrate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0700548:Metoprolol Tartrate [Organic Chemical,Pharmacologic Substance]
   861   C0039328:tartrate [Carbohydrate]
   861   C0144544:tartrate [Organic Chemical,Pharmacologic Substance]

Phrase: "propranolol hydrochloride,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0282321:Propranolol Hydrochloride [Organic Chemical,Pharmacologic Substance]
   944 E C0591636:Inderal [Organic Chemical,Pharmacologic Substance]
   861   C0033497:Propranolol [Organic Chemical,Pharmacologic Substance]
   861   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "alprenolol hydrochloride,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282044:Alprenolol Hydrochloride [Organic Chemical,Pharmacologic Substance]
   861   C0002334:Alprenolol [Organic Chemical,Pharmacologic Substance]
   861   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "atenolol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004147:Atenolol [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.66: Among them, bendroflumethiazide, furosemide, amiloride hydrochloride, and verapamil were used by more than 100 subjects. 

Phrase: "Among them,"

Phrase: "bendroflumethiazide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004975:Bendroflumethiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0701080:Naturetin [Organic Chemical,Pharmacologic Substance]

Phrase: "furosemide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016860:Furosemide [Organic Chemical,Pharmacologic Substance]
   944 E C0699992:Lasix [Organic Chemical,Pharmacologic Substance]

Phrase: "amiloride hydrochloride,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0546849:Amiloride Hydrochloride [Organic Chemical,Pharmacologic Substance]
   861   C0002502:Amiloride [Organic Chemical,Pharmacologic Substance]
   861   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "verapamil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042523:Verapamil [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "used by more"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   882   C1273517:Used by [Finding]
           used
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "than 100 subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.67: Statistical analysis Frequencies of variables between groups were examined by using the chi-square method. 

Phrase: "Statistical analysis Frequencies of variables"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   781   C1705502:Statistical Frequency [Quantitative Concept]
       E   Frequency
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]

Phrase: "between groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "examined by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the chi-square method."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
   734   C1552646:chi square [Quantitative Concept]
Processing 00000000.tx.68: Incidence rates were calculated by dividing the number of events by the number of person-years of follow-up. 

Phrase: "Incidence rates"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C1708485:Incidence Rate [Quantitative Concept]
   861   C0021149:Incidence [Quantitative Concept]
   861   C0220856:incidence [Functional Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   789 E C1551358:incident [Idea or Concept]

Phrase: "were"

Phrase: "calculated by dividing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332849:dividing [Functional Concept]
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "the number of events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "by the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of person-years"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0027361:Person [Population Group]
   861   C0439234:years [Temporal Concept]
   861   C2347489:Person [Group]
   827 E C0439508:/year [Temporal Concept]
   789 E C1519021:Personal [Organism Attribute]

Phrase: "of follow-up."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0589120:Follow-up [Finding]
  1000   C1522577:follow-up [Health Care Activity]
  1000   C1704685:FOLLOW-UP [Intellectual Product]
  1000   C3274571:FOLLOW-UP [Health Care Activity]
   861   C0332283:follow [Temporal Concept]
   861   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.69: The follow-up time for nondemented subjects was determined from the date of baseline interview to the date of follow-up examination or death. 

Phrase: "The follow-up time for nondemented subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0040223:Time [Temporal Concept]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]
   748   C3541383:Time [Temporal Concept]

Phrase: "was"

Phrase: "determined from the date of baseline interview"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0011008:Date [Temporal Concept]
   748   C0021822:Interview [Activity]
   748   C0168634:baseline [Biomedical or Dental Material]
   748   C0935630:Interview [Intellectual Product]
   748   C1442488:Baseline [Quantitative Concept]
   748   C2348077:Date [Food]

Phrase: "to the date"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "of follow-up examination"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0260832:Follow-up examination [Finding]
   734   C0589120:Follow-up [Finding]
   734   C1522577:follow-up [Health Care Activity]
   734   C1704685:FOLLOW-UP [Intellectual Product]
   734   C3274571:FOLLOW-UP [Health Care Activity]

Phrase: "or"

Phrase: "death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.70: For demented subjects, half of this time was assumed. 

Phrase: "For demented subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "half of this time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2825407:Half [Quantitative Concept]

Phrase: "was"

Phrase: "assumed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]
Processing 00000000.tx.71: We used the Cox proportional hazards regression model to calculate the relative risks of developing dementia in relation to APOE genotypes, according to use of antihypertensive medication. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Cox proportional hazards regression model to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C0033489:Proportional Hazards Model [Intellectual Product,Quantitative Concept]
   839   C0018623:Model, Hazards [Intellectual Product,Quantitative Concept]
   799   C3161035:Model [Intellectual Product]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the relative risks of developing dementia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0242492:Risks, Relative [Quantitative Concept]
   753   C0035647:Risks [Qualitative Concept]
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "in relation to APOE genotypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "according to use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of antihypertensive medication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]
Processing 00000000.tx.72: Because of limited numbers, we treated *2/*4, *3/*4, and *4/*4 as a group that we labeled *4, which was compared with *3/*3. 

Phrase: "Because of limited numbers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "*2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "*4,"

Phrase: "*3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "*4,"

Phrase: "and *"

Phrase: "4/"

Phrase: "*4 as a group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0441835:Group A [Classification]
   819   C0441876:Group 4 [Intellectual Product]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "that"

Phrase: "we"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "*4,"

Phrase: "which"

Phrase: "was"

Phrase: "compared with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Compared [Activity]

Phrase: "*3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "*3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.73: We considered age (in years), sex (female vs. male), education (<8 vs. 8 years), systolic blood pressure (two dummy variables, <130 and >160 compared with 130160 mmHg), heart disease (yes vs. no), and stroke (yes vs. no) as covariates in the models. 

Phrase: "We"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "age (in years"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1510829:Age, in Years [Temporal Concept]
           Age-Years
   790   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: ","

Phrase: "sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "(female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]

Phrase: "vs. male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]

Phrase: ")"

Phrase: ","

Phrase: "education"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "("

Phrase: "<8"

Phrase: "vs. 8 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "systolic blood pressure"
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
  1000   C0488055:Systolic blood pressure [Clinical Attribute]
  1000   C0871470:Systolic blood pressure [Clinical Attribute]
           Systolic Pressure
  1000   C1306620:systolic blood pressure [Diagnostic Procedure]
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0039155:Systolic [Temporal Concept]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "(two dummy variables,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439828:variables [Qualitative Concept]

Phrase: "<130"

Phrase: "and >"

Phrase: "160"

Phrase: "compared with 130160 mmHg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439475:mmHg [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: ")"

Phrase: ","

Phrase: "heart disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018799:Heart disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(yes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1549445:Yes [Idea or Concept]
  1000   C1705108:Yes [Conceptual Entity]

Phrase: "vs."

Phrase: "no"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "stroke"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "(yes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1549445:Yes [Idea or Concept]
  1000   C1705108:Yes [Conceptual Entity]

Phrase: "vs. no)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1298908:no [Idea or Concept]
  1000   C1549444:No [Idea or Concept]

Phrase: "as"

Phrase: "covariates in the models."
Processing 00000000.tx.74: When age at dementia onset was used as the time scale in the Cox proportional hazards regression model, as suggested by Korn et al. 

Phrase: "When"

Phrase: "age at dementia onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0206132:Onset Age [Quantitative Concept]
   770   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "used as the time scale"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0040223:Time [Temporal Concept]
   760   C0175659:Scale [Medical Device]
   760   C0349674:Scale [Intellectual Product]
   760   C1273517:used [Finding]
   760   C1947916:Scale [Activity]
   760   C3536777:Scale [Manufactured Object]
   760   C3541383:Time [Temporal Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "in the Cox proportional hazards regression model,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   888   C0033489:Proportional Hazards Model [Intellectual Product,Quantitative Concept]
   853   C0018623:Model, Hazards [Intellectual Product,Quantitative Concept]
   804   C3161035:Model [Intellectual Product]

Phrase: "as"

Phrase: "suggested by Korn et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1705535:Suggest [Idea or Concept]
Processing 00000000.tx.75: (43), very similar results were obtained. 

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "very similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.76: Therefore, this paper presents results from the models in which the follow-up time was used.  

Phrase: "Therefore,"

Phrase: "this paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "results from the models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in which"

Phrase: "the follow-up time"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0589120:Follow-up [Finding]
   901   C1522577:follow-up [Health Care Activity]
   901   C1704685:FOLLOW-UP [Intellectual Product]
   901   C3274571:FOLLOW-UP [Health Care Activity]
   827   C0040223:Time [Temporal Concept]
   827   C0332283:follow [Temporal Concept]
   827   C1719822:Follow [Intellectual Product]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.77: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Among the 1,301 subjects who participated in the follow-up evaluation, 224 were diagnosed as demented (164 Alzheimer's disease, 41 vascular dementia, 19 other dementias). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  Among the 1,301 subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C1514811:Reference [Idea or Concept]
   753   C1706462:Reference [Conceptual Entity]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "participated in the follow-up evaluation,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0589120:Follow-up [Finding]
   790   C1522577:follow-up [Health Care Activity]
   790   C1704685:FOLLOW-UP [Intellectual Product]
   790   C3274571:FOLLOW-UP [Health Care Activity]
   753   C0220825:Evaluation [Functional Concept]
   753   C0332283:follow [Temporal Concept]
   753   C1261322:Evaluation [Health Care Activity]
   753   C1719822:Follow [Intellectual Product]

Phrase: "224"

Phrase: "were"

Phrase: "diagnosed as demented"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011900:Diagnosed [Finding]
   790   C0860630:demented [Mental or Behavioral Dysfunction]

Phrase: "(164 Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "41 vascular dementia,"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
   901   C0011269:Dementia, Vascular [Disease or Syndrome]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
   711 E C0333275:Bloody [Qualitative Concept]

Phrase: "19"

Phrase: "other dementias"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ")."
Processing 00000000.tx.78: The mean follow-up interval for the cohort was 36.7 months, and the maximum was 63.1 months. 

Phrase: "The mean follow-up interval for the cohort"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1272706:Interval [Temporal Concept]
   744   C1552654:Interval [Idea or Concept]
   744   C1552713:Interval [Intellectual Product]

Phrase: "was"

Phrase: "36.7 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "and"

Phrase: "the maximum"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0806909:Maximum [Quantitative Concept]
  1000   C1552615:maximum [Quantitative Concept]
  1000   C2826546:MAXIMUM [Quantitative Concept]
   928 E C0205289:Maximal [Qualitative Concept]

Phrase: "was"

Phrase: "63.1 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.79: Use of antihypertensive medication was related to a significantly reduced risk of all dementias (relative risk (RR) = 0.7, 95 percent confidence interval (CI): 0.5, 0.9) and Alzheimer's disease (RR = 0.6, 95 percent CI: 0.4, 0.8). 

Phrase: "Use of antihypertensive medication"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   819   C0240320:MEDICATION USE [Finding]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "related to a significantly reduced risk of all dementias"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   742   C0035647:Risk [Qualitative Concept]
   742   C0392756:Reduced [Qualitative Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C0497327:Dementias [Mental or Behavioral Dysfunction]
   708 E C0011265:dementia [Mental or Behavioral Dysfunction]
   708 E C0163712:Relate [Organic Chemical]

Phrase: "(relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: ")"

Phrase: "= 0.7,"

Phrase: "95 percent confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: "(CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: ":"

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "0.9"

Phrase: ")"

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "= 0.6,"

Phrase: "95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.4,"

Phrase: "0.8"

Phrase: ")."
Processing 00000000.tx.80: APOE genotyping was available for 75.7 percent (n = 985) of the 1,301 subjects. 

Phrase: "APOE genotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1285573:Genotyping [Laboratory Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "available for 75.7 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]

Phrase: "(n = 985"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "of the 1,301 subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]
Processing 00000000.tx.81: Among those without APOE genotyping, compared with those with APOE genotyping, slightly more (not significant) subjects became demented during the follow-up period (all dementias, 19.6 vs. 16.4 percent; Alzheimer's disease, 13.3 vs. 12.4 percent). 

Phrase: "Among those without APOE genotyping,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1285573:Genotyping [Laboratory Procedure]

Phrase: "compared with those with APOE genotyping,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1285573:Genotyping [Laboratory Procedure]
   748   C1707455:Compared [Activity]

Phrase: "slightly more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750482:Slightly [Idea or Concept]

Phrase: "("

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: ")"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "became"

Phrase: "demented during the follow-up period"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0589120:Follow-up [Finding]
   790   C1522577:follow-up [Health Care Activity]
   790   C1704685:FOLLOW-UP [Intellectual Product]
   790   C3274571:FOLLOW-UP [Health Care Activity]
   753   C0332283:follow [Temporal Concept]
   753   C0439531:/period [Temporal Concept]
   753   C0860630:demented [Mental or Behavioral Dysfunction]
   753   C1719822:Follow [Intellectual Product]
   753   C1948053:Period [Temporal Concept]

Phrase: "("

Phrase: "all dementias,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "19.6"

Phrase: "vs. 16.4 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "; Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "13.3"

Phrase: "vs. 12.4 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.82: Among the 985 subjects for whom APOE genotyping was available, 162 dementia cases (122 Alzheimer's disease, 40 vascular or other dementias) were identified after the 3-year follow-up. 

Phrase: "Among the 985 subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "for whom APOE genotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1285573:Genotyping [Laboratory Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "available, 162 dementia cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "(122 Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "40 vascular"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "or"

Phrase: "other dementias"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "were"

Phrase: "identified after the 3-year"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205396:Identified [Qualitative Concept]
   760   C0439234:year [Temporal Concept]
   760   C0439508:/year [Temporal Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "follow-up."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0589120:Follow-up [Finding]
  1000   C1522577:follow-up [Health Care Activity]
  1000   C1704685:FOLLOW-UP [Intellectual Product]
  1000   C3274571:FOLLOW-UP [Health Care Activity]
   861   C0332283:follow [Temporal Concept]
   861   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.83: Compared with those who did not develop dementia, subjects who developed Alzheimer's disease were older (aged 83.2 (standard deviation, 4.9) years vs. aged 80.6 (standard deviation, 4.6) years; p <0.001), had less education (<8 years, 69.7 vs. 46.1 percent; p <0.001), were more likely to be female (88.5 vs. 73.0 percent; p <0.001), were more likely to have had a stroke (18.0 vs. 10.0 percent; p <0.001), and were less likely to use antihypertensive medication (34.4 vs. 44.7 percent; p = 0.03). 

Phrase: "Compared with those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "who"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "developed"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "were"

Phrase: "older"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0580836:Old [Temporal Concept]

Phrase: "(aged 83.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001779:Aged [Organism Attribute]
   827   C0001792:Aged [Population Group]
   827   C1999167:aged [Population Group]

Phrase: "(standard deviation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0871420:Standard deviation [Quantitative Concept]
   861   C0012727:Deviation [Spatial Concept]
   861   C0205419:Deviation [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1705236:Deviation [Finding]
   861   C2828392:Standard [Intellectual Product]

Phrase: "4.9"

Phrase: ")"

Phrase: "years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439234:years [Temporal Concept]
   966 E C0439508:/year [Temporal Concept]

Phrase: "vs. aged 80.6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001779:Aged [Organism Attribute]
   827   C0001792:Aged [Population Group]
   827   C1999167:aged [Population Group]

Phrase: "(standard deviation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0871420:Standard deviation [Quantitative Concept]
   861   C0012727:Deviation [Spatial Concept]
   861   C0205419:Deviation [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1705236:Deviation [Finding]
   861   C2828392:Standard [Intellectual Product]

Phrase: "4.6"

Phrase: ")"

Phrase: "years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439234:years [Temporal Concept]
   966 E C0439508:/year [Temporal Concept]

Phrase: "; p <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "had"

Phrase: "less education"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0013621:Education [Educational Activity]
   861   C0013622:education [Classification]
   861   C0013658:Education, NOS [Finding]
   861   C0039401:Education [Educational Activity]
   789 E C1555905:Educational [Intellectual Product]

Phrase: "("

Phrase: "<8 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "69.7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "vs. 46.1 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "; p <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]

Phrase: "(88.5"

Phrase: "vs. 73.0 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "; p <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "had"

Phrase: "a stroke"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "(18.0"

Phrase: "vs. 10.0 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "; p <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "were"

Phrase: "less likely to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332148:Likely [Qualitative Concept]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "(34.4"

Phrase: "vs. 44.7 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "; p = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.84: More Alzheimer's disease patients than those without dementia carried at least one APOE*4 allele (36.9 vs. 27.5 percent; p = 0.03). 

Phrase: "More Alzheimer's disease patients than those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "without dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "carried at least one APOE*4 allele"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   800   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   770   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0002085:Allele [Gene or Genome]
   744   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205447:One [Quantitative Concept]
   744   C0206243:carried [Activity]
   744   C0699809:carried [Finding]

Phrase: "(36.9"

Phrase: "vs. 27.5 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "; p = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.85: All of these differences between patients with and without dementia remained significant when we adjusted for age by using logistic regression. 

Phrase: "All of these differences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with"

Phrase: "and without dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C1515981:And [Idea or Concept]

Phrase: "remained"

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "when"

Phrase: "we"

Phrase: "adjusted for age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0456081:Adjusted [Functional Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "logistic regression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206031:Logistic Regression [Research Activity]
   861   C0242415:logistic [Occupational Activity]
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]
Processing 00000000.tx.86: Subjects who used antihypertensive medication at baseline (n = 432) were more likely to be female (p = 0.002) and to have a history of heart disease (p <0.001) or stroke (p <0.001) than those not using antihypertensive medication (table 1). 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication at baseline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003364:Antihypertensive [Pharmacologic Substance]
   770   C0013227:Medication, NOS [Pharmacologic Substance]
   770   C3244316:medication [Functional Concept]

Phrase: "(n = 432"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]

Phrase: "(p = 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a history of heart disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   816   C0683519:History of diseases [Finding]
           disease history
   760   C0019664:History [Occupation or Discipline]
   760   C0019665:history [Intellectual Product]
   760   C0262512:History, NOS [Organism Attribute]
   760   C0262926:History [Finding]
   760   C1705255:History [Conceptual Entity]
   760   C2004062:History [Finding]

Phrase: "(p <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "stroke"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "(p <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "than those"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "(table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: There were no significant differences in age, education, systolic blood pressure, or APOE genotypes between the two groups. 

Phrase: "There"

Phrase: "were"

Phrase: "no significant differences in age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0699810:age differences [Age Group]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "systolic blood pressure,"
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
  1000   C0488055:Systolic blood pressure [Clinical Attribute]
  1000   C0871470:Systolic blood pressure [Clinical Attribute]
           Systolic Pressure
  1000   C1306620:systolic blood pressure [Diagnostic Procedure]
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0039155:Systolic [Temporal Concept]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "or"

Phrase: "APOE genotypes between the two groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.88: The incidence of all dementias and of Alzheimer's disease was lower among subjects using versus not using antihypertensive medication. 

Phrase: "The incidence of all dementias"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "and of Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "lower among subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "versus"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]
Processing 00000000.tx.89: The adjusted relative risks of all dementias and Alzheimer's disease associated with use of antihypertensive medication were 0.6 (95 percent CI: 0.5, 0.9) and 0.5 (95 percent CI: 0.3, 0.8), respectively. 

Phrase: "The adjusted relative risks of all dementias"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0242492:Risks, Relative [Quantitative Concept]
   748   C0035647:Risks [Qualitative Concept]
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C0456081:Adjusted [Functional Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "associated with use of antihypertensive medication"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1524063:Use of [Functional Concept]
   783   C0240320:MEDICATION USE [Finding]
   753   C0003364:Antihypertensive [Pharmacologic Substance]
   753   C0013227:Medication, NOS [Pharmacologic Substance]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
   753   C3244316:medication [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "were"

Phrase: "0.6"

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "0.9"

Phrase: ")"

Phrase: "and"

Phrase: "0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.3,"

Phrase: "0.8"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.90: View this table: [in this window] [in a new window]  TABLE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.91: Characteristics of subjects, according to use of antihypertensive medication, in a community-based population aged 75 years and older, first follow-up of the Kungsholmen Project, Stockholm, Sweden, 19901992  The APOE*4 allele, compared with *3/*3, significantly increased the risk of dementia (RR = 1.5, 95 percent CI: 1.1, 2.1) and Alzheimer's disease (RR = 1.7, 95 percent CI: 1.2, 2.5). 

Phrase: "Characteristics of subjects,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C0681884:subject characteristics [Research Activity]
   841   C1519021:Subject Characteristics [Organism Attribute]
   841   C1706465:Subject Characteristics [Idea or Concept]
   790   C1521970:Characteristics [Qualitative Concept]

Phrase: "according to use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of antihypertensive medication,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "in a community-based population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "older, first follow-up of the Kungsholmen Project,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0589120:Follow-up [Finding]
   770   C1522577:follow-up [Health Care Activity]
   770   C1704685:FOLLOW-UP [Intellectual Product]
   770   C3274571:FOLLOW-UP [Health Care Activity]
   744   C0332283:follow [Temporal Concept]
   744   C1719822:Follow [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "19901992"

Phrase: "The APOE*4 allele,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "compared with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Compared [Activity]

Phrase: "*3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "*3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "= 1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "= 1.7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.92: The population attributable risks (44) of APOE*4 were 12.9 percent for all dementias and 16.4 percent for Alzheimer's disease. 

Phrase: "The population attributable risks"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1514229:Population Attributable Risk [Quantitative Concept]
   896   C0242444:population risk [Population Group]
   896   C2987720:Population risk [Quantitative Concept]
   867   C0814766:Attributable Risk [Qualitative Concept]
   827   C0032659:Population [Quantitative Concept]
   827   C0035647:Risks [Qualitative Concept]
   827   C0596130:Attributable [Mental Process]
   827   C1257890:Population [Population Group]

Phrase: "(44"

Phrase: ")"

Phrase: "of APOE*4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "12.9 percent for all dementias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439165:Percent [Quantitative Concept]

Phrase: "and"

Phrase: "16.4 percent for Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439165:Percent [Quantitative Concept]
Processing 00000000.tx.93: Among those not using antihypertensive medication, *4 carriers had a twofold higher risk of dementia and Alzheimer's disease compared with *3/*3 carriers (table 2). 

Phrase: "Among those"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "*4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "had"

Phrase: "a twofold higher risk of dementia"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C0332167:High risk of [Qualitative Concept]
           High Risk
   756   C3272283:High Risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "compared with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Compared [Activity]

Phrase: "*3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "*3 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "(table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: Carriers of the *2 allele were at a lower risk of dementia, but this finding was not significant. 

Phrase: "Carriers of the *2 allele"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0007294:carriers [Finding]
   726 E C0560175:Carrier [Finding]
   726 E C1706209:Carrier [Medical Device]
   726 E C3273162:Carrier [Intellectual Product]

Phrase: "were at a lower risk of dementia,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   762   C3272281:Low Risk [Finding]
   762   C3538919:Low Risk [Quantitative Concept]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0035647:Risk [Qualitative Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]
   714 E C0205251:low [Qualitative Concept]
   714 E C1299352:Low [Qualitative Concept]
   714 E C1550472:low [Idea or Concept]

Phrase: "but"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "was"

Phrase: "not significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.95: Among those who used antihypertensive medication, no significant difference was found in the incidence of dementia and Alzheimer's disease between *4 carriers and *3/*3 carriers (table 2). 

Phrase: "Among those"

Phrase: "who"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "found in the incidence of dementia"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0021149:Incidence [Quantitative Concept]
   753   C0150312:Found [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   719 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "Alzheimer's disease between"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0002395:Alzheimer's Disease [Disease or Syndrome]
   882   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "*4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "and *"

Phrase: "3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "*3 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "(table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.97: Incidence, * number of cases, relative risks (RR), and 95% confidence intervals (CI) of dementias, according to apolipoprotein E genotypes and use of antihypertensive medication, first follow-up of the Kungsholmen Project, Stockholm, Sweden, 19901992  The simultaneous effect of APOE*4 and antihypertensive medication was examined further by considering, as a reference group, all persons who did not carry the *4 allele and did not use antihypertensive medication (table 3). 

Phrase: "Incidence,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "* number of cases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "relative risks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Risks, Relative [Quantitative Concept]
   861   C0035647:Risks [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "95% confidence intervals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "(CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "of dementias,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "according to apolipoprotein E genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "use of antihypertensive medication,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   819   C0240320:MEDICATION USE [Finding]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "first follow-up of the Kungsholmen Project,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "19901992"

Phrase: "The simultaneous effect of APOE*4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "further by considering,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0750591:considering [Idea or Concept]
   790   C1517331:Further [Spatial Concept]
   756 E C0205108:far [Spatial Concept]

Phrase: "as"

Phrase: "a reference group,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0680399:reference group [Population Group]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1514811:Reference [Idea or Concept]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1706462:Reference [Conceptual Entity]

Phrase: "all persons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027361:Persons [Population Group]
   966 E C2347489:Person [Group]
   916 E C1519021:Personal [Organism Attribute]

Phrase: "who"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "the *4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.98: The risk of dementia and Alzheimer's disease associated with the APOE*4 allele differed according to use of antihypertensive medication. 

Phrase: "The risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "associated with the APOE*4 allele"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   814   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0002085:Allele [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "differed according to use of antihypertensive medication."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1524063:Use of [Functional Concept]
   774   C0240320:MEDICATION USE [Finding]
   748   C0003364:Antihypertensive [Pharmacologic Substance]
   748   C0013227:Medication, NOS [Pharmacologic Substance]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C0680240:according [Social Behavior]
   748   C1947944:Use [Intellectual Product]
   748   C3244316:medication [Functional Concept]
Processing 00000000.tx.99: We then divided the entire sample into three groups according to APOE genotypes. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "divided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:Divided [Functional Concept]

Phrase: "the entire sample into three groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "according to APOE genotypes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.100: A significantly reduced risk of dementia associated with use of antihypertensive medication was found for APOE*4 carriers only: the relative risks were 0.4 (95 percent CI: 0.2, 0.7) for all dementias and 0.3 (95 percent CI: 0.2, 0.7) for Alzheimer's disease. 

Phrase: "A significantly reduced risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: "associated with use of antihypertensive medication"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1524063:Use of [Functional Concept]
   783   C0240320:MEDICATION USE [Finding]
   753   C0003364:Antihypertensive [Pharmacologic Substance]
   753   C0013227:Medication, NOS [Pharmacologic Substance]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
   753   C3244316:medication [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "found for APOE*4 carriers only"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   814   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0007294:carriers [Finding]
   748   C0150312:Found [Quantitative Concept]
   748   C0205171:Only [Quantitative Concept]
   748   C1720467:Only [Intellectual Product]
   714 E C0243095:Find [Finding]
   714 E C0560175:Carrier [Finding]
   714 E C1706209:Carrier [Medical Device]
   714 E C3273162:Carrier [Intellectual Product]

Phrase: ":"

Phrase: "the relative risks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Risks, Relative [Quantitative Concept]
   861   C0035647:Risks [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "were"

Phrase: "0.4"

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.2,"

Phrase: "0.7"

Phrase: ")"

Phrase: "for all dementias"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "0.3"

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.2,"

Phrase: "0.7"

Phrase: ")"

Phrase: "for Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.101: View this table: [in this window] [in a new window]  TABLE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.102: Relative risks (RR)* and 95% confidence intervals (CI) of dementia, according to apolipoprotein E *4 allele and use of antihypertensive medication, first follow-up of the Kungsholmen Project, Stockholm, Sweden, 19901992  The same analyses were performed for subjects who had a baseline MMSE score of 23 (n = 938) and for those who participated in the follow-up clinical examination (n = 840). 

Phrase: "Relative risks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Risks, Relative [Quantitative Concept]
   861   C0035647:Risks [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: ")"

Phrase: "*"

Phrase: "and"

Phrase: "95% confidence intervals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "(CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "of dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "according to apolipoprotein E *4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "use of antihypertensive medication,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   819   C0240320:MEDICATION USE [Finding]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "first follow-up of the Kungsholmen Project,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "19901992"

Phrase: "The same analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed for subjects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0884358:Performed [Functional Concept]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "who"

Phrase: "had"

Phrase: "a baseline MMSE score of 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449820:Score [Quantitative Concept]

Phrase: "(n = 938"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and for those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "who"

Phrase: "participated in the follow-up clinical examination"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0260832:Follow-up examination [Finding]
   778   C0031809:Clinical examination [Health Care Activity]
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0205210:Clinical [Qualitative Concept]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]

Phrase: "(n = 840"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.103: All of these analyses produced very similar results concerning the relation between APOE*4 and dementia. 

Phrase: "All of these analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "produced"

Phrase: "very similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the relation between APOE*4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0080103:Relation [Family Group]
   753   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.104: There were no significant differences in baseline use of estrogens, nonsteroidal anti-inflammatory drugs, and salicylic acid agents between those who used and did not use antihypertensive medication. 

Phrase: "There"

Phrase: "were"

Phrase: "no significant differences in baseline use of estrogens,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "nonsteroidal anti-inflammatory drugs,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Antiinflammatory Drug [Pharmacologic Substance]
   923   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   861   C1515999:Anti-inflammatory [Qualitative Concept]
   812   C0013227:Drugs [Pharmacologic Substance]
   812   C0333348:Inflammatory [Functional Concept]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "salicylic acid agents between those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0450442:Agent [Chemical Viewed Functionally]
   726   C1254351:Agent [Pharmacologic Substance]
   726   C1521826:Agent [Intellectual Product]

Phrase: "who"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]
Processing 00000000.tx.105: Inclusion of the variables for these drugs in analyses did not change our results significantly. 

Phrase: "Inclusion of the variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512693:Inclusion [Qualitative Concept]

Phrase: "for these drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "in analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "our results significantly."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.106: Among those subjects using antihypertensive medication, 80 percent used diuretics (55 percent with diuretic monotherapy). 

Phrase: "Among those subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "80 percent used diuretics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012798:Diuretics [Pharmacologic Substance]

Phrase: "(55 percent with diuretic monotherapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439165:Percent [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.107: Among those using other antihypertensive drugs, about 50 percent used calcium channel antagonists and 45 percent used -blockers. 

Phrase: "Among those"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "other antihypertensive drugs,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0003364:Anti-Hypertensive Drugs [Pharmacologic Substance]
           Antihypertensive
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "about 50 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "calcium channel antagonists"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C2757014:Calcium Channel Antagonists [Molecular Function]
   901   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C0006684:calcium antagonist [Pharmacologic Substance]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0243076:antagonists [Chemical Viewed Functionally]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
   827   C2936886:Calcium [Pharmacologic Substance]
   793 E C0231491:Antagonist [Organ or Tissue Function]
   721 E C0680242:antagonism [Social Behavior]

Phrase: "and"

Phrase: "45 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439165:Percent [Quantitative Concept]

Phrase: "used -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "blockers."
Processing 00000000.tx.108: Table 4 shows the results when the population was divided into two groups by use of diuretics, regardless of other antihypertensive medications. 

Phrase: "Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "when"

Phrase: "the population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "was"

Phrase: "divided into two groups"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0205448:Two [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of diuretics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012798:Diuretics [Pharmacologic Substance]

Phrase: "regardless of other antihypertensive medications."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medications [Pharmacologic Substance]
   861   C0802604:Medications [Clinical Attribute]
   861   C2598133:Medications [Clinical Attribute]
   827 E C3244316:medication [Functional Concept]
Processing 00000000.tx.109: The population was then divided into three groups, the group receiving diuretic monotherapy, the group using other antihypertensive medications, and the group not using any antihypertensive medication. 

Phrase: "The population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "divided into three groups,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0205449:Three [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "diuretic monotherapy,"

Phrase: "the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "other antihypertensive medications,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medications [Pharmacologic Substance]
   861   C0802604:Medications [Clinical Attribute]
   861   C2598133:Medications [Clinical Attribute]
   827 E C3244316:medication [Functional Concept]

Phrase: "and"

Phrase: "the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "any antihypertensive medication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]
Processing 00000000.tx.110: APOE*4 carriers on diuretic monotherapy (n = 242) had relative risks of 0.9 (95 percent CI: 0.4, 2.0) for all dementias and 0.7 (95 percent CI: 0.3, 1.9) for Alzheimer's disease; 

Phrase: "APOE*4 carriers on diuretic monotherapy"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0007294:carriers [Finding]
   714 E C0560175:Carrier [Finding]
   714 E C1706209:Carrier [Medical Device]
   714 E C3273162:Carrier [Intellectual Product]

Phrase: "(n = 242"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "had"

Phrase: "relative risks of 0.9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0242492:Risks, Relative [Quantitative Concept]
   760   C0035647:Risks [Qualitative Concept]
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.4,"

Phrase: "2.0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "for all dementias"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "0.7"

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.3,"

Phrase: "1.9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.111: those carriers using other antihypertensive medications (n = 190) had relative risks of 1.0 (95 percent CI: 0.5, 2.4) for all dementias and 1.7 (95 percent CI: 0.6, 5.3) for Alzheimer's disease. 

Phrase: "those carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "other antihypertensive medications"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medications [Pharmacologic Substance]
   861   C0802604:Medications [Clinical Attribute]
   861   C2598133:Medications [Clinical Attribute]
   827 E C3244316:medication [Functional Concept]

Phrase: "(n = 190"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "had"

Phrase: "relative risks of 1.0"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0242492:Risks, Relative [Quantitative Concept]
   781   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0035647:Risks [Qualitative Concept]
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "2.4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "for all dementias"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "1.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.6,"

Phrase: "5.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "for Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.112: View this table: [in this window] [in a new window]  TABLE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.113: Relative risks (RR)* and 95% confidence intervals (CI) of dementia, according to apolipoprotein E genotypes and use of diuretics, first follow-up of the Kungsholmen Project, Stockholm, Sweden, 19901992   DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  In this large community-based cohort of persons aged 75 years and older, a significantly increased incidence of dementia and Alzheimer's disease was associated with the APOE*4 allele among those not using antihypertensive medication at baseline; 

Phrase: "Relative risks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Risks, Relative [Quantitative Concept]
   861   C0035647:Risks [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "(RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: ")"

Phrase: "*"

Phrase: "and"

Phrase: "95% confidence intervals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "(CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "of dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "according to apolipoprotein E genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "use of diuretics,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C1524063:Use of [Functional Concept]
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]

Phrase: "first follow-up of the Kungsholmen Project,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "19901992   DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  In this large community-based cohort of persons"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   742   C0009462:Community [Geographic Area]
   742   C0027361:Persons [Population Group]
   742   C0549177:Large [Quantitative Concept]
   742   C0599755:Cohort [Population Group]
   742   C1514811:Reference [Idea or Concept]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   742   C1706462:Reference [Conceptual Entity]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]
   708 E C2347489:Person [Group]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "older,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0580836:Old [Temporal Concept]

Phrase: "a significantly increased incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "associated with the APOE*4 allele"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   814   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0002085:Allele [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "among those"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication at baseline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003364:Antihypertensive [Pharmacologic Substance]
   770   C0013227:Medication, NOS [Pharmacologic Substance]
   770   C3244316:medication [Functional Concept]

Phrase: ";"
Processing 00000000.tx.114: this increased incidence was not found among those who used antihypertensive medication. 

Phrase: "this increased incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0021149:Incidence [Quantitative Concept]
   861   C0220856:incidence [Functional Concept]
   789 E C1551358:incident [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found among those"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "who"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]
Processing 00000000.tx.115: The latter group had a significantly decreased risk of dementia and Alzheimer's disease. 

Phrase: "The latter group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "had"

Phrase: "a significantly decreased risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.116: These results were derived from the analyses in which age, sex, education, systolic blood pressure, heart disease, and stroke were considered. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "derived from the analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "in which age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "systolic blood pressure,"
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
  1000   C0488055:Systolic blood pressure [Clinical Attribute]
  1000   C0871470:Systolic blood pressure [Clinical Attribute]
           Systolic Pressure
  1000   C1306620:systolic blood pressure [Diagnostic Procedure]
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0039155:Systolic [Temporal Concept]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "heart disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018799:Heart disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "stroke"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "were"

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.117: Our study may shed new light on the relation between APOE*4 and Alzheimer's disease. 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "shed"

Phrase: "new light on the relation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023693:Light [Natural Phenomenon or Process]
   760   C1306462:Light [Functional Concept]
   760   C1881376:Light [Qualitative Concept]

Phrase: "between APOE*4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.118: First, the large-scale, prospective data from a general population confirm the link between APOE*4 and Alzheimer's disease. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the large-scale, prospective data from a general population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1511726:Data [Idea or Concept]
   742   C3245479:data [Medical Device]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the link between APOE*4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.119: However, we estimated that only 12.9 percent of incident dementia cases and 16.4 percent of Alzheimer's disease cases could be accounted for by the *4 allele. 

Phrase: "However,"

Phrase: "we"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "that only 12.9 percent of incident dementia cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439165:Percent [Quantitative Concept]

Phrase: "and"

Phrase: "16.4 percent of Alzheimer's disease cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439165:Percent [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by the *4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.120: This result is very similar to that of a recent study concluding that 13.5 percent of incident Alzheimer's disease may be explained by *4 (24). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "very similar to that of a recent study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "concluding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that 13.5 percent of incident Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439165:Percent [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "explained by"

Phrase: "*4"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.121: The lower population attributable risk could be due to the decreased relative risk of Alzheimer's disease associated with the APOE*4 allele after age 70 years (45, 46) and to the lower frequency of the APOE*4 allele in the very old. 

Phrase: "The lower population attributable risk"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C1514229:Population Attributable Risk [Quantitative Concept]
   875   C0242444:population risk [Population Group]
   875   C2987720:Population risk [Quantitative Concept]
   861   C0814766:Attributable Risk [Qualitative Concept]
   812   C0032659:Population [Quantitative Concept]
   812   C0035647:Risk [Qualitative Concept]
   812   C0596130:Attributable [Mental Process]
   812   C1257890:Population [Population Group]

Phrase: "could"

Phrase: "be due to the decreased relative risk of Alzheimer's disease"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0242492:Relative Risk [Quantitative Concept]
   760   C0678226:Due to [Functional Concept]
           due
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C1281905:disease risk [Finding]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0035647:Risk [Qualitative Concept]
   739   C0080103:Relative [Family Group]
   739   C0205216:Decreased [Quantitative Concept]
   739   C0205345:Relative [Qualitative Concept]
   739   C0392756:Decreased [Qualitative Concept]
   739   C0442797:decreased [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]
   739   C2987476:Be [Conceptual Entity]
   739   C3146286:Due [Idea or Concept]
   706 E C0547047:Decrease [Quantitative Concept]

Phrase: "associated with the APOE*4 allele"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   814   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0002085:Allele [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "after age 70 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510829:Age-Years [Temporal Concept]
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "(45,"

Phrase: "46"

Phrase: ")"

Phrase: "and to the lower frequency of the APOE*4 allele"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   797   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   775   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   756   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0017270:Allele Frequency [Quantitative Concept]
   738   C0002085:Allele [Gene or Genome]
   738   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0376249:frequency [Quantitative Concept]
   738   C0439603:Frequency [Temporal Concept]
   738   C0441994:Lower [Spatial Concept]
   738   C0871396:Frequency [Quantitative Concept]
   738   C1515981:And [Idea or Concept]
   738   C1548802:Lower [Body Location or Region]
   738   C1561548:Frequency [Qualitative Concept]
   738   C1705502:Frequency [Quantitative Concept]
   738   C2003888:Lower [Activity]

Phrase: "in the very old."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0580836:Old [Temporal Concept]
Processing 00000000.tx.122: In a meta-analysis, the risk of Alzheimer's disease associated with the APOE*4 allele increased until age 60 years in *3/*4 and *4/*4 carriers and until age 70 years in *2/*4 carriers, and it diminished thereafter (14). 

Phrase: "In a meta-analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "associated with the APOE*4 allele"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   814   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0002085:Allele [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "increased until age 60 years in *3/"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   800   C1510829:Age, in Years [Temporal Concept]
           Age-Years
   748   C0001779:Age [Organism Attribute]
   748   C0205217:Increased [Quantitative Concept]
   748   C0439234:years [Temporal Concept]
   748   C0442805:Increased [Functional Concept]
   714 E C0439508:/year [Temporal Concept]

Phrase: "*4"

Phrase: "and *"

Phrase: "4/"

Phrase: "*4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "and until age 70 years in *2/"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   800   C1510829:Age, in Years [Temporal Concept]
           Age-Years
   748   C0001779:Age [Organism Attribute]
   748   C0439234:years [Temporal Concept]
   748   C1515981:And [Idea or Concept]
   714 E C0439508:/year [Temporal Concept]

Phrase: "*4 carriers,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "it"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "thereafter"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.123: Second, our finding of the lack of a significant association between *4 and Alzheimer's disease among those using antihypertensive medication supports a previous view that the effect of the APOE*4 allele is not uniform or is modifiable, as suggested in several studies (2527). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "our finding of the lack of a significant association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0037088:Finding [Sign or Symptom]
   742   C0243095:Finding [Finding]
   742   C2825141:Finding [Finding]

Phrase: "between"

Phrase: "*4"

Phrase: "and"

Phrase: "Alzheimer's disease among those"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a previous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Previous [Temporal Concept]
  1000   C1552607:previous [Temporal Concept]

Phrase: "view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that"

Phrase: "the effect of the APOE*4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "not uniform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205375:Uniform [Qualitative Concept]
   861   C1608508:uniform [Quantitative Concept]

Phrase: "or"

Phrase: "is"

Phrase: "modifiable,"

Phrase: "as"

Phrase: "suggested in several studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737   C1705535:Suggest [Idea or Concept]
   737 E C2603343:Study [Research Activity]

Phrase: "(2527"

Phrase: ")."
Processing 00000000.tx.124: Third, antihypertensive medication use significantly decreased the incidence of dementia; 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "significantly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: ";"
Processing 00000000.tx.125: the effect was more pronounced in those subjects with the APOE*4 allele. 

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced in those subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with the APOE*4 allele."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.126: The probable explanation for these results is that antihypertensive medication can significantly reduce the number of cerebrovascular events or lesions now believed to be important in the pathogenesis of both Alzheimer's disease and vascular dementia, and that there may be an interaction between cerebrovascular disease and APOE*4 on dementia (47, 48). 

Phrase: "The probable explanation for these results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "can"

Phrase: "significantly"

Phrase: "reduce"

Phrase: "the number of cerebrovascular events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "or"

Phrase: "lesions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221198:Lesion [Finding]
  1000   C1546698:Lesion [Intellectual Product]

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important in the pathogenesis of both Alzheimer's disease"

Phrase: "and"

Phrase: "vascular dementia,"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "that there"

Phrase: "may"

Phrase: "be"

Phrase: "an interaction between cerebrovascular disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "APOE*4 on dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(47,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.127: A recent clinical trial showed that antihypertensive treatment reduced the incidence of dementia by 50 percent (49). 

Phrase: "A recent clinical trial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0008976:Clinical Trial [Research Activity]
           Trial
   901   C1096775:Clinical Trial [Intellectual Product]
   827   C0205210:Clinical [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that antihypertensive treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "by 50 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439165:Percent [Quantitative Concept]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.128: It is unlikely that the lower risk associated with use of antihypertensive medication was due to the potential protective effect of the *2 allele (50), as we found no differences in the frequencies of APOE genotypes between the two groups. 

Phrase: "It"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the lower risk"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   983   C3272281:Low Risk [Finding]
   983   C3538919:Low Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]
   827 E C0205251:low [Qualitative Concept]
   827 E C1299352:Low [Qualitative Concept]
   827 E C1550472:low [Idea or Concept]

Phrase: "associated with use of antihypertensive medication"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1524063:Use of [Functional Concept]
   783   C0240320:MEDICATION USE [Finding]
   753   C0003364:Antihypertensive [Pharmacologic Substance]
   753   C0013227:Medication, NOS [Pharmacologic Substance]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
   753   C3244316:medication [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was due to the potential protective effect of the *2 allele"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0678226:Due to [Functional Concept]
           due
   738   C0002085:Allele [Gene or Genome]
   738   C0043194:WAS [Disease or Syndrome]
   738   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1280500:Effect [Qualitative Concept]
   738   C1421478:WAS [Gene or Genome]
   738   C2348382:Effect [Qualitative Concept]
   738   C3146286:Due [Idea or Concept]
   738   C3245505:Potential [Qualitative Concept]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no differences in the frequencies of APOE genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "between the two groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.129: If we assume that *4 carriers using antihypertensive medication have the same risk of Alzheimer's disease as *4 carriers not using antihypertensive medication, there would be no difference in the incidence of Alzheimer's disease between the two groups. 

Phrase: "If"

Phrase: "we"

Phrase: "assume"

Phrase: "that"

Phrase: "*4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "have"

Phrase: "the same risk of Alzheimer's disease as *4 carriers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1281905:disease risk [Finding]
   742   C0035647:Risk [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "there"

Phrase: "would"

Phrase: "be"

Phrase: "no difference in the incidence of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "between the two groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.130: Subjects who use antihypertensive medication may differ in many aspects, including genetic factors, from those who do not use these drugs. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "may"

Phrase: "differ in many aspects,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1547011:Aspect [Quantitative Concept]
   737   C1879746:Aspect [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "genetic factors,"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "from those"

Phrase: "who"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "these drugs."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.131: Use of these drugs may just be a marker of an unknown factor or factors that can modify the effect of APOE*4 and thereby reduce the incidence of Alzheimer's disease. 

Phrase: "Use of these drugs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   802   C0242510:drug use [Mental or Behavioral Dysfunction]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "may"

Phrase: "just"

Phrase: "be"

Phrase: "a marker of an unknown factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005516:Marker [Clinical Attribute]

Phrase: "or"

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "can"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the effect of APOE*4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "reduce"

Phrase: "the incidence of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]
Processing 00000000.tx.132: However, there were no significant differences in baseline use of estrogens, nonsteroidal anti-inflammatory drugs, and salicylic acid agents between those who did and did not use antihypertensive medication. 

Phrase: "However,"

Phrase: "there"

Phrase: "were"

Phrase: "no significant differences in baseline use of estrogens,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "nonsteroidal anti-inflammatory drugs,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Antiinflammatory Drug [Pharmacologic Substance]
   923   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   861   C1515999:Anti-inflammatory [Qualitative Concept]
   812   C0013227:Drugs [Pharmacologic Substance]
   812   C0333348:Inflammatory [Functional Concept]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "salicylic acid agents between those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0450442:Agent [Chemical Viewed Functionally]
   726   C1254351:Agent [Pharmacologic Substance]
   726   C1521826:Agent [Intellectual Product]

Phrase: "who"

Phrase: "did"

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]
Processing 00000000.tx.133: We also examined several other drugs, including other cardiovascular agents, and did not find that these drugs could account for the results. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other drugs,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "other cardiovascular agents,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007220:Cardiovascular Agents [Pharmacologic Substance]
   983 E C2697969:Cardiovascular Agent [Chemical Viewed Functionally]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "these drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "could"

Phrase: "account for the results."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]
Processing 00000000.tx.134: In this study, the diagnosis of dementia was based on clinical data. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the diagnosis of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "based on clinical data."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C1516606:Clinical Data [Intellectual Product]
   802   C0242356:data base [Intellectual Product]
   802   C0993637:Data Base [Intellectual Product]
   770   C0205210:Clinical [Qualitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.135: No neuroimaging and/or pathologic data were available for the diagnosis of dementia and Alzheimer's disease. 

Phrase: "No neuroimaging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679575:Neuroimaging [Diagnostic Procedure]

Phrase: "and/or"

Phrase: "pathologic data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "available for the diagnosis of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0470187:Available [Functional Concept]
           Availability of

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.136: We could not distinguish definite Alzheimer's disease from probable Alzheimer's disease. 

Phrase: "We"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "distinguish"

Phrase: "definite Alzheimer's disease from probable Alzheimer's disease."
Processing 00000000.tx.137: Misclassification of dementia and dementia types may have occurred, leading to decreased power in detecting small effects. 

Phrase: "Misclassification of dementia"

Phrase: "and"

Phrase: "dementia types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332307:Types [Qualitative Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "leading to decreased power"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0032863:Power [Human-caused Phenomenon or Process]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in detecting small effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.138: However, it is unlikely that differential misclassification occurred. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that differential misclassification"

Phrase: "occurred."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.139: In fact, had we classified more Alzheimer's disease patients as non-Alzheimer's disease patients in the group that used antihypertensive medication, because they were more likely to have had heart disease and stroke, we would have expected an excess of non-Alzheimer's disease cases to be associated with *4 in the group. 

Phrase: "In fact,"

Phrase: "had"

Phrase: "we"

Phrase: "classified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008902:Classified [Classification]

Phrase: "more Alzheimer's disease patients as non-Alzheimer's disease patients"

Phrase: "in the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "that used antihypertensive medication,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003364:Antihypertensive [Pharmacologic Substance]
   827   C0013227:Medication, NOS [Pharmacologic Substance]
   827   C3244316:medication [Functional Concept]

Phrase: "because"

Phrase: "they"

Phrase: "were"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "had"

Phrase: "heart disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018799:Heart disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "stroke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "we"

Phrase: "would"

Phrase: "have"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "an excess of non-Alzheimer's disease cases to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1979886:Excess [Qualitative Concept]

Phrase: "be"

Phrase: "associated with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C0750490:Associate [Idea or Concept]
   799 E C1706221:Associate [Professional or Occupational Group]

Phrase: "*4 in the group."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0441876:Group 4 [Intellectual Product]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
Processing 00000000.tx.140: However, this was not the case. 

Phrase: "However,"

Phrase: "this"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.141: Importantly, the results were consistent for all dementias and for Alzheimer's disease. 

Phrase: "Importantly,"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "consistent for all dementias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332290:Consistent [Idea or Concept]

Phrase: "and for Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.142: The first limitation of this study is that about 24 percent of eligible subjects did not undergo APOE genotyping. 

Phrase: "The first limitation of this study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449295:Limitation [Functional Concept]

Phrase: "is"

Phrase: "that about 24 percent of eligible subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0439165:Percent [Quantitative Concept]
   748   C1548635:eligible [Idea or Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "undergo"

Phrase: "APOE genotyping."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1285573:Genotyping [Laboratory Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.143: Although the dropout rate was lower in this study than in previous studies, caution is necessary in interpreting the results. 

Phrase: "Although"

Phrase: "the dropout rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "lower in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in previous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "caution"

Phrase: "is"

Phrase: "necessary in interpreting"

Phrase: "the results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.144: However, there was no significant difference in the cumulative incidence of dementia and Alzheimer's disease between those with and without APOE genotyping. 

Phrase: "However,"

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in the cumulative incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease between those with"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "and without APOE genotyping."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1285573:Genotyping [Laboratory Procedure]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.145: Also, among those subjects without APOE genotyping, use of antihypertensive medication was associated with a lower incidence of dementia and Alzheimer's disease, although this finding was not significant. 

Phrase: "Also,"

Phrase: "among those subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "without APOE genotyping,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1285573:Genotyping [Laboratory Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "use of antihypertensive medication"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   819   C0240320:MEDICATION USE [Finding]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "associated with a lower incidence of dementia"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0021149:Incidence [Quantitative Concept]
   748   C0220856:incidence [Functional Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "although"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "was"

Phrase: "not significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.146: The second limitation is use of a two-phase design in the initial survey of prevalent cases. 

Phrase: "The second limitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449295:Limitation [Functional Concept]

Phrase: "is"

Phrase: "use of a two-phase design"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0205390:Phase [Temporal Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0457083:Use [Functional Concept]
   753   C1707689:Design [Activity]
   753   C1947944:Use [Intellectual Product]
   753   C2983265:DESIGN [Intellectual Product]

Phrase: "in the initial survey"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038951:Survey [Intellectual Product]

Phrase: "of prevalent cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.147: We estimated that 26 patients might have been missing from the screening test (51) and were thereby possibly included in the cohort of 1,301 participants in the follow-up assessment. 

Phrase: "We"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "that 26 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "might"

Phrase: "have"

Phrase: "been"

Phrase: "missing from the screening test"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C0871311:screening test [Health Care Activity]
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1551393:Missing [Idea or Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1705492:Missing [Qualitative Concept]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]
   760   C3272743:MISSING [Qualitative Concept]
   726 E C1305399:screen [Functional Concept]
   726 E C1705053:Screen [Medical Device]
   726 E C2349206:Miss [Conceptual Entity]

Phrase: "(51"

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "thereby possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2362652:Possibly [Qualitative Concept]

Phrase: "included in the cohort of 1,301 participants"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0332257:included [Functional Concept]
   744   C0599755:Cohort [Population Group]
   744   C0679646:participants [Population Group]
   744   C3538986:INCLUDED [Gene or Genome]
   711 E C1552866:include [Idea or Concept]
   711 E C2698741:Participant [Classification]
   711 E C2700399:Include [Activity]

Phrase: "in the follow-up assessment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1261322:Assessment [Health Care Activity]
   827   C1516048:Assessment [Activity]
   734   C0589120:Follow-up [Finding]
   734   C1522577:follow-up [Health Care Activity]
   734   C1704685:FOLLOW-UP [Intellectual Product]
   734   C3274571:FOLLOW-UP [Health Care Activity]
Processing 00000000.tx.148: This problem may have led to an overestimation of the total incidence of dementia. 

Phrase: "This problem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033213:Problem [Finding]

Phrase: "may"

Phrase: "have"

Phrase: "led to an overestimation of the total incidence of dementia."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   741   C0555878:Total lead [Inorganic Chemical]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0021149:Incidence [Quantitative Concept]
   739   C0220856:incidence [Functional Concept]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C1708698:LED [Manufactured Object]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C1522538:Lead [Functional Concept]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.149: However, there is no reason to think that it may have significantly biased our results of the relation between APOE*4 and Alzheimer's disease. 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "no reason to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:Reason [Idea or Concept]

Phrase: "think"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:think [Mental Process]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "have"

Phrase: "significantly"

Phrase: "biased"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242568:Biased [Idea or Concept]
   966 E C1504315:Bias [Bird]

Phrase: "our results of the relation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "between APOE*4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.150: The third limitation is that the groups using antihypertensive medication were relatively small. 

Phrase: "The third limitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449295:Limitation [Functional Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "were"

Phrase: "relatively small."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]
Processing 00000000.tx.151: This problem might have reduced power to detect the difference in risk between *3/*3 and *4 and resulted in the wide range of confidence intervals that occurred. 

Phrase: "This problem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033213:Problem [Finding]

Phrase: "might"

Phrase: "have"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "power"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the difference in risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "between"

Phrase: "*3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "*3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and *"

Phrase: "4"

Phrase: "and"

Phrase: "resulted in the wide range of confidence intervals"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   770   C0009667:Confidence Intervals [Quantitative Concept]
   744   C0237529:Confidence [Mental Process]
   744   C0332464:Wide [Spatial Concept]
   744   C1272706:intervals [Temporal Concept]
   744   C1514721:Range [Quantitative Concept]
   744   C1704725:Confidence [Qualitative Concept]
   744   C1704726:Confidence [Mental Process]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711 E C1552654:Interval [Idea or Concept]
   711 E C1552713:Interval [Intellectual Product]
   711   C2825142:Result [Finding]

Phrase: "that"

Phrase: "occurred."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.152: Some confidence intervals overlapped between *4 carriers who did and did not use antihypertensive medication if different references were used (table 2). 

Phrase: "Some confidence intervals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0009667:Confidence Intervals [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:intervals [Temporal Concept]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: "overlapped between"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0185027:overlapped [Therapeutic or Preventive Procedure]
   799 E C1948020:Overlap [Conceptual Entity]

Phrase: "*4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "who"

Phrase: "did"

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "if"

Phrase: "different references"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514811:Reference [Idea or Concept]
   827   C1706462:Reference [Conceptual Entity]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.153: However, there was little overlap if the same reference was used (tables 3 and 4). 

Phrase: "However,"

Phrase: "there"

Phrase: "was"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "overlap"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:overlap [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlap [Conceptual Entity]

Phrase: "if"

Phrase: "the same reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(tables 3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.154: Furthermore, among those using antihypertensive medication, 80 percent used diuretics. 

Phrase: "Furthermore,"

Phrase: "among those"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "80 percent used diuretics."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012798:Diuretics [Pharmacologic Substance]
Processing 00000000.tx.155: Although all results associated with use of antihypertensive medication were mostly due to use of diuretics, a similar trend for all dementias was also found with use of other antihypertensive medications. 

Phrase: "Although"

Phrase: "all results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "associated with use of antihypertensive medication"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1524063:Use of [Functional Concept]
   783   C0240320:MEDICATION USE [Finding]
   753   C0003364:Antihypertensive [Pharmacologic Substance]
   753   C0013227:Medication, NOS [Pharmacologic Substance]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
   753   C3244316:medication [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "were"

Phrase: "mostly due to use of diuretics,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0678226:Due to [Functional Concept]
           due
   790   C1524063:Use of [Functional Concept]
   753   C0012798:Diuretics [Pharmacologic Substance]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C0750554:mostly [Idea or Concept]
   753   C1947944:Use [Intellectual Product]
   753   C3146286:Due [Idea or Concept]

Phrase: "a similar trend for all dementias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521798:trend [Temporal Concept]

Phrase: "was"

Phrase: "also"

Phrase: "found with use of other antihypertensive medications."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C1524063:Use of [Functional Concept]
   774   C0240320:medications use [Finding]
   748   C0003364:Antihypertensive [Pharmacologic Substance]
   748   C0013227:Medications [Pharmacologic Substance]
   748   C0042153:use [Functional Concept]
   748   C0150312:Found [Quantitative Concept]
   748   C0457083:Use [Functional Concept]
   748   C0802604:Medications [Clinical Attribute]
   748   C1947944:Use [Intellectual Product]
   748   C2598133:Medications [Clinical Attribute]
   714 E C0243095:Find [Finding]
   714 E C3244316:medication [Functional Concept]
Processing 00000000.tx.156: However, it seemed that use of other antihypertensive medications mainly affected the relation between APOE*4 and vascular or other dementias. 

Phrase: "However,"

Phrase: "it"

Phrase: "seemed"

Phrase: "that use of other antihypertensive medications mainly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1524063:Use of [Functional Concept]
   774   C0240320:medications use [Finding]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the relation between APOE*4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0080103:Relation [Family Group]
   753   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "vascular"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005847:vascular [Body Part, Organ, or Organ Component]
  1000   C1558950:VASCULAR [Finding]
  1000   C1801960:Vascular [Qualitative Concept]
   944 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   944 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C0005767:Blood [Tissue]
   900 E C0005768:blood [Body Substance]
   900 E C0229664:Blood [Body Substance]
   900 E C0392895:Bloods [Population Group]
   884 E C0333275:Bloody [Qualitative Concept]

Phrase: "or"

Phrase: "other dementias."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.157: Alternatively, this finding could have been due to misclassification between types of dementia in the group using other antihypertensive drugs. 

Phrase: "Alternatively,"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "could"

Phrase: "have"

Phrase: "been due to misclassification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0678226:Due to [Functional Concept]
           due
   770   C3146286:Due [Idea or Concept]

Phrase: "between types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332307:Types [Qualitative Concept]
   966 E C1547052:*Type [Quantitative Concept]

Phrase: "of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "in the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "other antihypertensive drugs."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0003364:Anti-Hypertensive Drugs [Pharmacologic Substance]
           Antihypertensive
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.158: The fourth limitation is the lack of information on duration of drug use. 

Phrase: "The fourth limitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449295:Limitation [Functional Concept]

Phrase: "is"

Phrase: "the lack of information"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "on duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "of drug use."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242510:drug use [Mental or Behavioral Dysfunction]
   861   C0042153:use [Functional Concept]
   861   C0457083:Use [Functional Concept]
   861   C1947944:Use [Intellectual Product]
Processing 00000000.tx.159: Generally, this limitation may have decreased the power to detect a given association or led to an underestimation of the association. 

Phrase: "Generally,"

Phrase: "this limitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:Limitation [Functional Concept]

Phrase: "may"

Phrase: "have"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a given association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "or"

Phrase: "led to an underestimation of the association."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.160: We performed Cox regression analyses by using age at onset as the time scale, which produced similar results. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Cox regression analyses by"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0034980:Regression Analyses [Intellectual Product]
   770   C0684320:Regression [Pathologic Function]
   770   C0684321:Regression [Mental Process]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "age at onset as the time scale,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0206132:Onset Age [Quantitative Concept]
   774   C0449244:onset time [Temporal Concept]
   748   C0001779:Age [Organism Attribute]
   748   C0332162:Onset [Qualitative Concept]

Phrase: "which"

Phrase: "produced"

Phrase: "similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.161: Finally, unlike a clinical trial, our study was not designed to specifically assess the effects of antihypertensive medication. 

Phrase: "Finally,"

Phrase: "unlike a clinical trial,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008976:Clinical Trial [Research Activity]
           Trial
  1000   C1096775:Clinical Trial [Intellectual Product]
   861   C0205210:Clinical [Qualitative Concept]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effects of antihypertensive medication."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C1319171:Medication effects [Finding]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.162: In our cohort, the group using antihypertensive medication may have differed in many ways from the group not using antihypertensive medication. 

Phrase: "In our cohort,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599755:Cohort [Population Group]

Phrase: "the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "may"

Phrase: "have"

Phrase: "differed in many ways"

Phrase: "from the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]
Processing 00000000.tx.163: Although we adjusted for a number of variables, including drugs that have been reported to protect against Alzheimer's disease, we cannot rule out the possibility that our results were biased by factors that we did not examine. 

Phrase: "Although"

Phrase: "we"

Phrase: "adjusted for a number of variables,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0237753:*Number [Quantitative Concept]
   753   C0439828:variables [Qualitative Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C0456081:Adjusted [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect against Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "biased by factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0242568:Biased [Idea or Concept]
   756 E C1504315:Bias [Bird]
   756   C1521761:Factor [Functional Concept]
   756   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "examine."
Processing 00000000.tx.164: In conclusion, our large-scale prospective data support the view that the APOE*4 allele is an important risk factor for late-onset dementia and Alzheimer's disease. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our large-scale prospective data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that"

Phrase: "the APOE*4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "an important risk factor for late-onset dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035648:Risk factor [Quantitative Concept]
   744   C0035647:Risk [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.165: However, this allele may account for only less than 20 percent of incident cases in people aged 75 years and older. 

Phrase: "However,"

Phrase: "this allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "may"

Phrase: "account for only less"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205171:Only [Quantitative Concept]
   770   C1551359:account [Idea or Concept]
   770   C1720467:Only [Intellectual Product]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "than 20 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439165:Percent [Quantitative Concept]

Phrase: "of incident cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1551358:incident [Idea or Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "in people"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027361:People [Population Group]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "older."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0580836:Old [Temporal Concept]
Processing 00000000.tx.166: Furthermore, a significant association between the APOE*4 allele and dementia or Alzheimer's disease was found only among those not using antihypertensive medication (80 percent used diuretics). 

Phrase: "Furthermore,"

Phrase: "a significant association between the APOE*4 allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "only among those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antihypertensive medication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003364:Antihypertensive [Pharmacologic Substance]
   861   C0013227:Medication, NOS [Pharmacologic Substance]
   861   C3244316:medication [Functional Concept]

Phrase: "(80 percent used diuretics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012798:Diuretics [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.167: Use of these drugs was related to a significantly reduced incidence of dementia and Alzheimer's disease, which was more pronounced among APOE*4 carriers. 

Phrase: "Use of these drugs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   802   C0242510:drug use [Mental or Behavioral Dysfunction]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "related to a significantly reduced incidence of dementia"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0021149:Incidence [Quantitative Concept]
   744   C0220856:incidence [Functional Concept]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]
   711 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "which"

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced among APOE*4 carriers."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007294:carriers [Finding]
   719 E C0560175:Carrier [Finding]
   719 E C1706209:Carrier [Medical Device]
   719 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.168: Further studies are needed to clarify whether these drugs, especially diuretics, can modify the effect of the APOE*4 allele. 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "whether"

Phrase: "these drugs,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "especially diuretics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012798:Diuretics [Pharmacologic Substance]

Phrase: "can"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the effect of the APOE*4 allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.169: At this time, antihypertensive drugs should not be prescribed to treat or prevent dementia.  

Phrase: "At this time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "antihypertensive drugs"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0003364:Anti-Hypertensive Drugs [Pharmacologic Substance]
           Antihypertensive
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "prescribed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0278329:Prescribed [Health Care Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "or"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.170: ACKNOWLEDGMENTS  This study was supported by grants from the Swedish Medical Research Council, the Swedish Council for Social Research, the Swedish Municipal Pension Institute, the National Corporation of Swedish Pharmacies' Fund for Research and Studies in Health Economics and Social Pharmaceutics, the Torsten and Ragnar Sderbergs Foundation, and the Foundation for Medical Research (Stiftelsen Hjlp till Medicin Forskning). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Swedish Medical Research Council,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0079816:Medical Research [Research Activity]
   861   C1556038:Medical Research [Professional or Occupational Group]
   812   C0035168:research [Research Activity]
   812   C0205476:Medical [Functional Concept]
   812   C0242481:Research [Research Activity]
   812   C1551807:Council [Population Group]

Phrase: "the Swedish Council for Social Research,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1551807:Council [Population Group]

Phrase: "the Swedish Municipal Pension Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "the National Corporation of Swedish Pharmacies' Fund"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0683758:Corporation [Organization]

Phrase: "for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "and"

Phrase: "Studies in Health Economics"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0013560:health economics [Occupation or Discipline]
   770   C0013556:Economics [Occupation or Discipline]
   770   C0013557:economics [Functional Concept]
   770   C0018684:Health [Idea or Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "Social Pharmaceutics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031336:Pharmaceutics [Biomedical Occupation or Discipline]

Phrase: "the Torsten"

Phrase: "and"

Phrase: "Ragnar Sderbergs Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Foundation for Medical Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016617:Foundation [Organization]
   756   C2986512:Research Base [Organization]

Phrase: "(Stiftelsen Hjlp till Medicin Forskning"

Phrase: ")."
Processing 00000000.tx.171: The authors thank all Kungsholmen Project workers for collecting and managing the data. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "all Kungsholmen Project workers for collecting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0024752:workers [Functional Concept]
   753   C1306056:workers [Occupation or Discipline]
   753   C1527116:Workers [Population Group]

Phrase: "and"

Phrase: "managing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1273870:Managing [Occupational Activity]

Phrase: "the data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]
Processing 00000000.tx.172: They also thank Lena Lilius, Benita Engvall, and Inga Volkmann for their invaluable technical assistance.  

Phrase: "They also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Lena Lilius,"

Phrase: "Benita Engvall,"

Phrase: "and"

Phrase: "Inga Volkmann for their invaluable technical assistance."
Processing 00000000.tx.173: NOTES  Reprint requests to Dr. 

Phrase: "NOTES"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Dr."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031831:DR [Professional or Occupational Group]
   790   C0686900:request [Functional Concept]
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.174: Zhenchao Guo, Stockholm Gerontology Research Center, Box 6401, S-113 82 Stockholm, Sweden (e-mail: Li.Zhu{at}cnsf.ki.se ).  

Phrase: "Zhenchao Guo,"

Phrase: "Stockholm Gerontology Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0683939:research center [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]

Phrase: "Box 6401,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "S-"

Phrase: "113 82 Stockholm,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Li.Zhu{at}cnsf.ki.se"

Phrase: ")."
Processing 00000000.tx.175: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Breitner JCS, Welsh KA. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Breitner JCS,"

Phrase: "Welsh KA."
Processing 00000000.tx.176: Genes and recent developments in the epidemiology of Alzheimer's disease and related dementia. 

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "recent developments in the epidemiology of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0243107:development [Physiologic Function]
   711   C0678723:Development [Organism Function]
   711   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "related dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.177: Epidemiol Rev 1995;17:3947.[ISI][Medline] Strittmatter WJ, Roses AD. 

Phrase: "Epidemiol Rev 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ";17"

Phrase: ":"

Phrase: "3947."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strittmatter WJ,"

Phrase: "Roses AD."
Processing 00000000.tx.178: Apolipoprotein E and Alzheimer disease. 

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.179: Proc Natl Acad Sci U S A 1995;92:47257.[Abstract] Saunders AM, Strittmatter WJ, Schmechel D, et al. 

Phrase: "Proc Natl Acad Sci U S A 1995"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ";92"

Phrase: ":"

Phrase: "47257."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Saunders"

Phrase: "AM"

Phrase: ","

Phrase: "Strittmatter WJ,"

Phrase: "Schmechel D,"

Phrase: "et al."
Processing 00000000.tx.180: Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. 

Phrase: "Association of apolipoprotein E allele 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "with late-onset familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.181: Neurology 1993;43:146772.[Abstract] Poirier J, Davignon J, Bouthillier D, et al. 

Phrase: "Neurology 1993"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";43"

Phrase: ":"

Phrase: "146772."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Poirier J,"

Phrase: "Davignon J,"

Phrase: "Bouthillier D,"

Phrase: "et al."
Processing 00000000.tx.182: Apolipoprotein E polymorphism and Alzheimer's disease. 

Phrase: "Apolipoprotein E polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.183: Lancet 1993;342:6979.[ISI][Medline] Corder EH, Saunders AM, Strittmatter WJ, et al. 

Phrase: "Lancet 1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ";342"

Phrase: ":"

Phrase: "6979."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corder EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Saunders"

Phrase: "AM"

Phrase: ","

Phrase: "Strittmatter WJ,"

Phrase: "et al."
Processing 00000000.tx.184: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. 

Phrase: "Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.185: Science 1993;261:9213.[ISI][Medline] Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, et al. 

Phrase: "Science 1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ";261"

Phrase: ":"

Phrase: "9213."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yoshizawa T,"

Phrase: "Yamakawa-Kobayashi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Komatsuzaki Y,"

Phrase: "et al."
Processing 00000000.tx.186: Dose-dependent association of apolipoprotein E allele 4 with late-onset, sporadic Alzheimer's disease. 

Phrase: "Dose-dependent association of apolipoprotein E allele 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "with late-onset, sporadic Alzheimer's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   924   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0205422:Sporadic [Temporal Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.187: Ann Neurol 1994;36:6569.[ISI][Medline] Kuusisto J, Koivisto K, Kervinen K, et al. 

Phrase: "Ann Neurol 1994"

Phrase: ";36"

Phrase: ":"

Phrase: "6569."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kuusisto J,"

Phrase: "Koivisto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kervinen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.188: Association of apolipoprotein E genotypes with late onset Alzheimer's disease: population based study. 

Phrase: "Association of apolipoprotein E genotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with late onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "population based study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709599:Population Based Study [Research Activity]
   913   C0681876:Population Study [Research Activity]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.189: BMJ 1994;309:6368.[Abstract/Free FullText] Nalbantoglu J, Gilfix BM, Bertrand P, et al. 

Phrase: "BMJ 1994"

Phrase: ";309"

Phrase: ":"

Phrase: "6368."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nalbantoglu J,"

Phrase: "Gilfix BM,"

Phrase: "Bertrand P,"

Phrase: "et al."
Processing 00000000.tx.190: Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. 

Phrase: "Predictive value of apolipoprotein E genotyping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514307:Predictive Value [Qualitative Concept]
   753   C0681890:predictive [Qualitative Concept]
   753   C1522609:Value [Quantitative Concept]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "results of an autopsy series"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "an analysis of several combined studies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.191: Ann Neurol 1994;36:88995.[ISI][Medline] Mayers RH, Schaefer EJ, Wilson PWF, et al. 

Phrase: "Ann Neurol 1994"

Phrase: ";36"

Phrase: ":"

Phrase: "88995."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mayers RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Schaefer EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Wilson PWF,"

Phrase: "et al."
Processing 00000000.tx.192: Apolipoprotein E 4 association with dementia in a population-based study: the Framingham Study. 

Phrase: "Apolipoprotein E 4 association with dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "in a population-based study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709599:Population Based Study [Research Activity]
   913   C0681876:Population Study [Research Activity]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "the Framingham Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.193: Neurology 1996;46:6737.[Abstract] Mak YT, Chiu H, Woo J, et al. 

Phrase: "Neurology 1996"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";46"

Phrase: ":"

Phrase: "6737."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mak YT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412122:YT [Gene or Genome]

Phrase: "Chiu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Woo J,"

Phrase: "et al."
Processing 00000000.tx.194: Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. 

Phrase: "Apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer's disease in Hong Kong elderly Chinese."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.195: Neurology 1996;46:1469.[Abstract] Payami H, Zareparsi S, Montee KR, et al. 

Phrase: "Neurology 1996"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";46"

Phrase: ":"

Phrase: "1469."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Payami H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Zareparsi S,"

Phrase: "Montee KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.196: Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. 

Phrase: "Gender difference in apolipoprotein E-associated risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0036866:gender difference [Organism Attribute]
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "for familial Alzheimer disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ":"

Phrase: "a possible clue to the higher incidence of Alzheimer disease"

Phrase: "in women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.197: Am J Hum Genet 1996;58:80311.[ISI][Medline] Bickebller H, Campion D, Brice A, et al. 

Phrase: "Am"

Phrase: "J Hum Genet 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";58"

Phrase: ":"

Phrase: "80311."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bickebller H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Campion D,"

Phrase: "Brice A,"

Phrase: "et al."
Processing 00000000.tx.198: Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. 

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "genotype-specific risks by age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risks [Qualitative Concept]

Phrase: "and"

Phrase: "sex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]
Processing 00000000.tx.199: Am J Hum Genet 1997;60:43946.[ISI][Medline] Katzman R, Zhang MY, Chen PJ, et al. 

Phrase: "Am"

Phrase: "J Hum Genet 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";60"

Phrase: ":"

Phrase: "43946."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Katzman R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Zhang"

Phrase: "MY,"

Phrase: "Chen PJ,"

Phrase: "et al."
Processing 00000000.tx.200: Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. 

Phrase: "Effects of apolipoprotein E"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "aging in the Shanghai Survey of Dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0001811:Ageing [Organism Function]
Processing 00000000.tx.201: Neurology 1997;49:77985.[Abstract] Farrer LA, Cupples LA, Haines JL, et al. 

Phrase: "Neurology 1997"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";49"

Phrase: ":"

Phrase: "77985."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Farrer LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Cupples LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Haines JL,"

Phrase: "et al."
Processing 00000000.tx.202: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. 

Phrase: "Effects of age,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "ethnicity on the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015031:Ethnicity [Population Group]
   770   C0243103:ethnicity [Qualitative Concept]

Phrase: "between apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "a meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.203: JAMA 1997;278:134956.[Abstract] Slooter AJC, Cruts M, Kalmijn S, et al. 

Phrase: "JAMA 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";278"

Phrase: ":"

Phrase: "134956."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Slooter AJC,"

Phrase: "Cruts M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kalmijn S,"

Phrase: "et al."
Processing 00000000.tx.204: Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. 

Phrase: "Risk estimates of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1519101:Risk Estimate [Quantitative Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C0750572:estimates [Quantitative Concept]

Phrase: "by apolipoprotein E genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from a population-based incidence study"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1709599:Population Based Study [Research Activity]
   902   C0681876:Population Study [Research Activity]
   861   C0021150:Study, Incidence [Quantitative Concept]
   812   C0021149:Incidence [Quantitative Concept]
   812   C0220856:incidence [Functional Concept]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
   741 E C1551358:incident [Idea or Concept]

Phrase: ":"

Phrase: "the Rotterdam Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.205: Arch Neurol 1998;55:9648.[Abstract/Free FullText] Quiroga P, Calvo C, Albala C, et al. 

Phrase: "Arch Neurol 1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ";55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "9648."

Phrase: "[Abstract/Free FullText"

Phrase: "] Quiroga P,"

Phrase: "Calvo C,"

Phrase: "Albala C,"

Phrase: "et al."
Processing 00000000.tx.206: Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease. 

Phrase: "Apolipoprotein E polymorphism in elderly Chilean people"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.207: Neuroepidemiology 1999;18:4852.[ISI][Medline] Breitner JCS, Wyse BW, Anthony JC, et al. 

Phrase: "Neuroepidemiology 1999"

Phrase: ";18"

Phrase: ":"

Phrase: "4852."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Breitner JCS,"

Phrase: "Wyse BW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005910:BW [Organism Attribute]
   861   C0006041:BW [Geographic Area]
   861   C2986891:BW [Idea or Concept]

Phrase: "Anthony JC,"

Phrase: "et al."
Processing 00000000.tx.208: APOE-4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. 

Phrase: "APOE-4 count"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0750480:Count [Activity]
   812   C1705566:Count [Quantitative Concept]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "predicts"

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "when"

Phrase: "prevalence of AD increases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "declines"

Phrase: ":"

Phrase: "the Cache County Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.209: Neurology 1999;53:32131.[Abstract/Free FullText] Feskens EJM, Havekes LM, Kalmijn S, et al. 

Phrase: "Neurology 1999"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";53"

Phrase: ":"

Phrase: "32131."

Phrase: "[Abstract/Free FullText"

Phrase: "] Feskens EJM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0270853:EJM [Disease or Syndrome]

Phrase: "Havekes LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Kalmijn S,"

Phrase: "et al."
Processing 00000000.tx.210: Apolipoprotein 4 allele and cognitive decline in elderly men. 

Phrase: "Apolipoprotein 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "cognitive decline in elderly men."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.211: BMJ 1994;309:12026.[Abstract/Free FullText] Hyman BT, Gomez-Isla T, Briggs M, et al. 

Phrase: "BMJ 1994"

Phrase: ";309"

Phrase: ":"

Phrase: "12026."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hyman BT,"

Phrase: "Gomez-Isla T,"

Phrase: "Briggs M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.212: Apolipoprotein E and cognitive change in an elderly population. 

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "cognitive change in an elderly population."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1392786:Cognitive Change [Mental or Behavioral Dysfunction]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1516691:Cognitive [Functional Concept]
   753   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.213: Ann Neurol 1996;40:5566.[Medline] Yaffe K, Cauley J, Sands L, et al. 

Phrase: "Ann Neurol 1996"

Phrase: ";40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "5566."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yaffe K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cauley J,"

Phrase: "Sands L,"

Phrase: "et al."
Processing 00000000.tx.214: Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. 

Phrase: "Apolipoprotein E phenotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0428504:Apolipoprotein E phenotype [Laboratory or Test Result]
  1000   C0430038:Apolipoprotein E phenotype [Laboratory Procedure]
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "cognitive decline in a prospective study of elderly community women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.215: Arch Neurol 1997;54:111014.[Abstract] Jonker C, Schmand B, Lindeboom J, et al. 

Phrase: "Arch Neurol 1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ";54"

Phrase: ":"

Phrase: "111014."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jonker C,"

Phrase: "Schmand B,"

Phrase: "Lindeboom J,"

Phrase: "et al."
Processing 00000000.tx.216: Association between apolipoprotein E 4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. 

Phrase: "Association between apolipoprotein E 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "the rate of cognitive decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "in community-dwelling elderly individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "with"

Phrase: "and without dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.217: Arch Neurol 1998;55:10659.[Abstract/Free FullText] Petersen RC, Smith GE, Ivnik RJ, et al. 

Phrase: "Arch Neurol 1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ";55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "10659."

Phrase: "[Abstract/Free FullText"

Phrase: "] Petersen RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Smith GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "Ivnik RJ,"

Phrase: "et al."
Processing 00000000.tx.218: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. 

Phrase: "Apolipoprotein E status as a predictor of the development of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0449438:Status [Qualitative Concept]

Phrase: "in memory-impaired individuals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]
   734   C0233794:MEMORY IMPAIRED [Mental or Behavioral Dysfunction]
Processing 00000000.tx.219: JAMA 1995;273:12748.[Abstract] Tierney MC, Szalai JP, Snow WG, et al. 

Phrase: "JAMA 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";273"

Phrase: ":"

Phrase: "12748."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tierney MC,"

Phrase: "Szalai JP,"

Phrase: "Snow WG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]

Phrase: "et al."
Processing 00000000.tx.220: A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. 

Phrase: "A prospective study of the clinical utility of ApoE genotype"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033522:prospective study [Research Activity]
   760   C1709709:Prospective Study [Research Activity]
   757   C0008972:Clinical Study [Research Activity]
   739   C0023981:prospective [Research Activity]
   739   C0557651:Study [Manufactured Object]
   739   C2603343:Study [Research Activity]

Phrase: "in the prediction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:Prediction [Idea or Concept]

Phrase: "of outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1274040:Outcome [Functional Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with memory impairment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0233794:Memory impairment [Mental or Behavioral Dysfunction]
  1000   C1963167:Memory impairment [Finding]
   861   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.221: Neurology 1996;46:14954.[Abstract] Evans DA, Beckett LA, Field TS, et al. 

Phrase: "Neurology 1996"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";46"

Phrase: ":"

Phrase: "14954."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Evans DA,"

Phrase: "Beckett LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Field TS,"

Phrase: "et al."
Processing 00000000.tx.222: Apolipoprotein E 4 and incidence of Alzheimer's disease in a community population of older persons. 

Phrase: "Apolipoprotein E 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "incidence of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "in a community population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "of older persons."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027361:Persons [Population Group]
   827 E C2347489:Person [Group]
   777 E C1519021:Personal [Organism Attribute]
Processing 00000000.tx.223: JAMA 1997;277:8224.[Abstract] Sobel E, Louhija J, Sulkava R, et al. 

Phrase: "JAMA 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";277"

Phrase: ":"

Phrase: "8224."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sobel E,"

Phrase: "Louhija J,"

Phrase: "Sulkava R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.224: Lack of association of apolipoprotein E allele 4 with late-onset Alzheimer's disease among Finnish centenarians. 

Phrase: "Lack of association of apolipoprotein E allele 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332268:lack [Qualitative Concept]

Phrase: "with late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "among Finnish centenarians."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007667:Centenarians [Age Group]
Processing 00000000.tx.225: Neurology 1996;45:9037.[Abstract] Osuntokun BO, Sahota A, Ogunniyi AO, et al. 

Phrase: "Neurology 1996"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";45"

Phrase: ":"

Phrase: "9037."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Osuntokun BO,"

Phrase: "Sahota A,"

Phrase: "Ogunniyi AO,"

Phrase: "et al."
Processing 00000000.tx.226: Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. 

Phrase: "Lack of an association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "between apolipoprotein E epsilon 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439098:Epsilon [Intellectual Product]

Phrase: "and"

Phrase: "Alzheimer's disease in elderly Nigerians."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.227: Ann Neurol 1995;38:4635.[ISI][Medline] Tang MX, Stern Y, Marder K, et al. 

Phrase: "Ann Neurol 1995"

Phrase: ";38"

Phrase: ":"

Phrase: "4635."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tang MX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025885:MX [Geographic Area]
   861   C0445039:MX [Finding]
   861   C1551087:Mx [Quantitative Concept]

Phrase: "Stern Y,"

Phrase: "Marder K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.228: The APOE-4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics. 

Phrase: "The APOE-4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "the risk of Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "among African Americans,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085756:African Americans [Population Group]
   861   C0027567:African [Population Group]
   861   C0596070:americans [Population Group]

Phrase: "Whites,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007457:Whites [Population Group]
  1000   C0043157:Whites [Population Group]
   966 E C0220938:White [Qualitative Concept]

Phrase: "and"

Phrase: "Hispanics."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0086409:Hispanics [Population Group]
   966 E C0019576:Hispanic [Population Group]
Processing 00000000.tx.229: JAMA 1998;279:7515.[Abstract/Free FullText] Jarvik GP, Larson EB, Goddard K, et al. 

Phrase: "JAMA 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";279"

Phrase: ":"

Phrase: "7515."

Phrase: "[Abstract/Free FullText"

Phrase: "] Jarvik GP,"

Phrase: "Larson EB,"

Phrase: "Goddard K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.230: Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. 

Phrase: "Influence of apolipoprotein E genotype"

Phrase: "on the transmission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040722:transmission [Idea or Concept]
  1000   C0242781:Transmission [Pathologic Function]
  1000   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "of Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in a community-based sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.231: Am J Hum Genet 1996;58:191200.[ISI][Medline] Mui S, Briggs M, Chung H, et al. 

Phrase: "Am"

Phrase: "J Hum Genet 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";58"

Phrase: ":"

Phrase: "191200."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mui S,"

Phrase: "Briggs M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chung H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.232: A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the 4 allele. 

Phrase: "A newly identified polymorphism in the apolipoprotein E enhancer gene region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0678951:gene polymorphism [Genetic Function]
   738   C0032529:Polymorphism [Genetic Function]
   738   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with Alzheimer's disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "strongly with the 4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.233: Neurology 1996;47:196201.[Abstract] Fratiglioni L, Viitanen M, Bckman L, et al. 

Phrase: "Neurology 1996"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";47"

Phrase: ":"

Phrase: "196201."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fratiglioni L,"

Phrase: "Viitanen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bckman L,"

Phrase: "et al."
Processing 00000000.tx.234: Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. 

Phrase: "Occurrence of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243132:occurrence [Functional Concept]
   790   C1554210:occurrence [Idea or Concept]
   790   C2745955:Occurrence [Temporal Concept]

Phrase: "in advanced age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Advanced age [Population Group]
   861   C0001779:Age [Organism Attribute]

Phrase: ":"

Phrase: "the study design of the Kungsholmen Project."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0035171:Study Design [Research Activity]
   778   C2983265:Study Design [Intellectual Product]
           DESIGN
   778   C2986888:Study Design [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C1707689:Design [Activity]
   748   C2603343:Study [Research Activity]
Processing 00000000.tx.235: Neuroepidemiology 1992;11(suppl 1):2936. 

Phrase: "Neuroepidemiology 1992"

Phrase: ";11"

Phrase: "(suppl 1"

Phrase: ")"

Phrase: ":"

Phrase: "2936."
Processing 00000000.tx.236: Guo Z, Fratiglioni L, Zhu L, et al. 

Phrase: "Guo Z,"

Phrase: "Fratiglioni L,"

Phrase: "Zhu L,"

Phrase: "et al."
Processing 00000000.tx.237: Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. 

Phrase: "Occurrence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243132:occurrence [Functional Concept]
  1000   C1554210:occurrence [Idea or Concept]
  1000   C2745955:Occurrence [Temporal Concept]

Phrase: "and"

Phrase: "progression of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "in a community population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "older"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0580836:Old [Temporal Concept]

Phrase: ":"

Phrase: "relationship of antihypertensive medication use."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.238: Arch Neurol 1999;56:9916.[Abstract/Free FullText] Folstein MF, Folstein SE, McHugh PR. 

Phrase: "Arch Neurol 1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ";56"

Phrase: ":"

Phrase: "9916."

Phrase: "[Abstract/Free FullText"

Phrase: "] Folstein MF,"

Phrase: "Folstein SE,"

Phrase: "McHugh PR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]
Processing 00000000.tx.239: "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. 

Phrase: """Mini-mental state"""
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   901   C0278060:Mental state [Finding]
   827   C0229992:mental [Mental Process]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   743 E C0229993:Psychic [Functional Concept]
   727 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   727 E C0042241:DIAPHRAGM [Medical Device]
   727 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   727 E C1705367:Diaphragm [Medical Device]
   716 E C0086045:mindfulness [Mental Process]
   716 E C3542996:Mindfulness [Mental Process]

Phrase: ":"

Phrase: "a practical method for grading"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "the cognitive state of patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0683521:Patient State [Finding]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1516691:Cognitive [Functional Concept]
   760   C3148680:State [Geographic Area]

Phrase: "for the clinician."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871685:Clinician [Professional or Occupational Group]
  1000   C1550470:clinician [Idea or Concept]
Processing 00000000.tx.240: J Psychiatr Res 1975;12:18998.[ISI][Medline] Fratiglioni L, Grut M, Forsell Y, et al. 

Phrase: "J Psychiatr Res 1975"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ";12"

Phrase: ":"

Phrase: "18998."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fratiglioni L,"

Phrase: "Grut M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Forsell Y,"

Phrase: "et al."
Processing 00000000.tx.241: Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. 

Phrase: "Prevalence of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "other dementias in an elderly urban population"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0497327:Dementias [Mental or Behavioral Dysfunction]
   714 E C0011265:dementia [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "relationship with age,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439849:Relationship [Qualitative Concept]
   790   C1705630:Relationship [Idea or Concept]
   790   C1706279:Relationship [Idea or Concept]
   790   C3540605:Relationship [Intellectual Product]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "education."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]
Processing 00000000.tx.242: Neurology 1991;41:188692.[Abstract] American Psychiatric Association. 

Phrase: "Neurology 1991"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";41"

Phrase: ":"

Phrase: "188692."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] American Psychiatric Association."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0004083:Association [Mental Process]
   827   C0205487:Psychiatric [Functional Concept]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   755 E C0033872:Psychiatry [Professional or Occupational Group]
   755 E C0033873:Psychiatry [Biomedical Occupation or Discipline]
Processing 00000000.tx.243: Diagnostic and statistical manual of mental disorders: DSM-III-R. 

Phrase: "Diagnostic and statistical manual of mental disorders"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C1136324:Diagnostic and Statistical Manual of Mental Disorders [Intellectual Product]
   877   C0599833:Diagnostic and Statistical Manual [Intellectual Product]
   818   C0004936:Mental disorders [Mental or Behavioral Dysfunction]
   795   C0011900:Diagnostic [Finding]
   795   C0012634:Disorders [Disease or Syndrome]
   795   C0024763:Manual [Intellectual Product,Manufactured Object]
   795   C0038215:Statistical [Occupation or Discipline]
   795   C0175674:Manual [Functional Concept]
   795   C0229992:mental [Mental Process]
   795   C0348026:Diagnostic [Functional Concept]
   785 E C0033975:mental disorder [Mental or Behavioral Dysfunction]
   768 E C0152097:diaphragm disorders [Disease or Syndrome]
   760 E C0277577:PSYCHIC DISORDER [Mental or Behavioral Dysfunction]
   712 E C0229993:Psychic [Functional Concept]

Phrase: ":"

Phrase: "DSM-III-R."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0220951:DSM III-R [Intellectual Product]
   901   C0444969:III/R [Intellectual Product]
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   734   C0679229:DSM-III [Intellectual Product]
Processing 00000000.tx.244: 3rd ed., rev. 

Phrase: "3rd ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.245: Washington, DC: American Psychiatric Association, 1987. 

Phrase: "Washington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:Washington [Geographic Area]

Phrase: "DC"

Phrase: ":"

Phrase: "American Psychiatric Association,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0004083:Association [Mental Process]
   827   C0205487:Psychiatric [Functional Concept]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   755 E C0033872:Psychiatry [Professional or Occupational Group]
   755 E C0033873:Psychiatry [Biomedical Occupation or Discipline]

Phrase: "1987."
Processing 00000000.tx.246: McKhann G, Drachman D, Folstein M, et al. 

Phrase: "McKhann G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Drachman D,"

Phrase: "Folstein M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.247: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. 

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA Work Group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of Department of Health and Human Services Task Force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.248: Neurology 1984;34:93944.[Abstract] Fratiglioni L, Viitanen M, von Strauss E, et al. 

Phrase: "Neurology 1984"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";34"

Phrase: ":"

Phrase: "93944."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fratiglioni L,"

Phrase: "Viitanen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "von Strauss E,"

Phrase: "et al."
Processing 00000000.tx.249: Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. 

Phrase: "Very old women at highest risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0043210:Women [Population Group]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "incidence data from the Kungsholmen Project,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "Stockholm."
Processing 00000000.tx.250: Neurology 1997;48:1328.[Abstract] Guo Z, Fratiglioni L, Winblad B, et al. 

Phrase: "Neurology 1997"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";48"

Phrase: ":"

Phrase: "1328."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Guo Z,"

Phrase: "Fratiglioni L,"

Phrase: "Winblad B,"

Phrase: "et al."
Processing 00000000.tx.251: Blood pressure and performance on the Mini-Mental State Examination in the very old: cross-sectional and longitudinal data from the Kungsholmen Project. 

Phrase: "Blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "performance on the Mini-Mental State Examination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0597198:Performance [Individual Behavior]
   748   C1882330:Performance [Activity]

Phrase: "in the very old"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0580836:Old [Temporal Concept]

Phrase: ":"

Phrase: "cross-sectional"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   964   C0552389:cross sections [Spatial Concept]
   861   C0205155:Sectional [Spatial Concept]
   861   C2828360:Cross [Conceptual Entity]
   789 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   789 E C1522472:Section [Substance]
   789 E C1552923:Section [Quantitative Concept]
   789 E C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "longitudinal data from the Kungsholmen Project."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]
Processing 00000000.tx.252: Am J Epidemiol 1997;145:110613.[Abstract] Wenham PR, Price WH, Blundell G. 

Phrase: "Am"

Phrase: "J Epidemiol 1997"

Phrase: ";145"

Phrase: ":"

Phrase: "110613."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wenham PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Price WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Blundell G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.253: Apolipoprotein E genotyping by one-stage PCR. 

Phrase: "Apolipoprotein E genotyping by one-stage PCR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.254: Lancet 1991;337:11589.[Medline] Basun H, Corder EH, Guo Z, et al. 

Phrase: "Lancet 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ";337"

Phrase: ":"

Phrase: "11589."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Basun H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Corder EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Guo Z,"

Phrase: "et al."
Processing 00000000.tx.255: Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. 

Phrase: "Apolipoprotein E polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "stroke in a population sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0038454:Stroke [Disease or Syndrome]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "or"

Phrase: "more."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]
Processing 00000000.tx.256: Stroke 1996;27:131015.[Abstract/Free FullText] Wills P, Fastbom J, Claesson CB, et al. 

Phrase: "Stroke 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Stroke [Disease or Syndrome]

Phrase: ";27"

Phrase: ":"

Phrase: "131015."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wills P,"

Phrase: "Fastbom J,"

Phrase: "Claesson CB,"

Phrase: "et al."
Processing 00000000.tx.257: Use of cardiovascular drugs in an older Swedish population. 

Phrase: "Use of cardiovascular drugs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   802   C0242510:drug use [Mental or Behavioral Dysfunction]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "in an older Swedish population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1518563:Older Population [Population Group]
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.258: J Am Geriatr Soc 1996;44:5460.[ISI][Medline] Guo Z, Wills P, Viitanen M, et al. 

Phrase: "J"

Phrase: "Am"

Phrase: "Geriatr Soc 1996"

Phrase: ";44"

Phrase: ":"

Phrase: "5460."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Guo Z,"

Phrase: "Wills P,"

Phrase: "Viitanen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.259: Cognitive impairment, drug use, and the risk of hip fracture in the very old: a prospective study. 

Phrase: "Cognitive impairment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "drug use,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242510:drug use [Mental or Behavioral Dysfunction]
   861   C0042153:use [Functional Concept]
   861   C0457083:Use [Functional Concept]
   861   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "the risk of hip fracture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in the very old"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0580836:Old [Temporal Concept]

Phrase: ":"

Phrase: "a prospective study."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0033522:prospective study [Research Activity]
  1000   C1709709:Prospective Study [Research Activity]
   861   C0023981:prospective [Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.260: Am J Epidemiol 1998;148:88792.[Abstract] Guidelines for ATC classification. 

Phrase: "Am"

Phrase: "J Epidemiol 1998"

Phrase: ";148"

Phrase: ":"

Phrase: "88792."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Guidelines for ATC classification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0162791:Guidelines [Intellectual Product]
   753   C0220845:guidelines [Intellectual Product]
   753   C0282423:guidelines [Intellectual Product]
Processing 00000000.tx.261: Uppsala, Sweden: Nordic Council on Medicines, 1985. 

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ":"

Phrase: "Nordic Council on Medicines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1551807:Council [Population Group]

Phrase: "1985."
Processing 00000000.tx.262: (NLN publication no. 16). 

Phrase: "(NLN publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034036:Publication [Intellectual Product,Manufactured Object]
   861   C0034037:Publication [Occupational Activity]
   861   C1704324:Publication [Intellectual Product]

Phrase: "no. 16"

Phrase: ")."
Processing 00000000.tx.263: Korn EL, Graubard BI, Midthune D. 

Phrase: "Korn EL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "Graubard BI,"

Phrase: "Midthune D."
Processing 00000000.tx.264: Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. 

Phrase: "Time-to-event analysis of longitudinal follow-up of a survey"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1718396:Time of analysis [Temporal Concept]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "choice of the time-scale."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0008300:choice [Individual Behavior]
   760   C1707391:Choice [Activity]
Processing 00000000.tx.265: Am J Epidemiol 1997;145:7280.[Abstract] Kelsey JL, Thompson WD, Evans AS. 

Phrase: "Am"

Phrase: "J Epidemiol 1997"

Phrase: ";145"

Phrase: ":"

Phrase: "7280."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kelsey JL,"

Phrase: "Thompson WD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019202:WD [Disease or Syndrome]
   861   C0332135:WD [Qualitative Concept]
   861   C1862191:WD [Intellectual Product]
   861   C3538902:WD [Gene or Genome]

Phrase: "Evans"

Phrase: "AS."
Processing 00000000.tx.266: Methods in observational epidemiology. 

Phrase: "Methods in observational epidemiology."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   802   C0014503:Epidemiology, Method [Research Activity]
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.267: New York, NY: Oxford University Press, 1986. 

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ":"

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "1986."
Processing 00000000.tx.268: Rebeck GW, Perls TT, West HL, et al. 

Phrase: "Rebeck GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "Perls TT,"

Phrase: "West HL,"

Phrase: "et al."
Processing 00000000.tx.269: Reduced apolipoprotein 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. 

Phrase: "Reduced apolipoprotein 4 allele frequency in the oldest old Alzheimer's patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0017270:Allele Frequency [Quantitative Concept]
   738   C0376249:frequency [Quantitative Concept]
   738   C0439603:Frequency [Temporal Concept]
   738   C0871396:Frequency [Quantitative Concept]
   738   C1561548:Frequency [Qualitative Concept]
   738   C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "cognitively normal individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]
Processing 00000000.tx.270: Neurology 1994;44:151316.[Abstract] Blaker D, Haines JL, Rodes L, et al. 

Phrase: "Neurology 1994"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";44"

Phrase: ":"

Phrase: "151316."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Blaker D,"

Phrase: "Haines JL,"

Phrase: "Rodes L,"

Phrase: "et al."
Processing 00000000.tx.271: ApoE-4 and age at onset of Alzheimer disease: the NIMH genetic initiative. 

Phrase: "ApoE-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "age at onset of Alzheimer disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   783   C0277793:disease onset [Temporal Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]

Phrase: ":"

Phrase: "the NIMH genetic initiative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424093:Initiative [Mental Process]
Processing 00000000.tx.272: Neurology 1997;48:13947.[Abstract] Kalmijn S, Feskens EJM, Launer LJ, et al. 

Phrase: "Neurology 1997"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";48"

Phrase: ":"

Phrase: "13947."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kalmijn S,"

Phrase: "Feskens EJM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0270853:EJM [Disease or Syndrome]

Phrase: "Launer LJ,"

Phrase: "et al."
Processing 00000000.tx.273: Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. 

Phrase: "Cerebrovascular disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007820:Cerebrovascular disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1880018:Cerebrovascular [Qualitative Concept]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the apolipoprotein e4 allele,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   827   C0002085:Allele [Gene or Genome]
   734   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "cognitive decline in a community-based study of elderly men."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.274: Stroke 1996;27:22305.[Abstract/Free FullText] Zhu L, Fratiglioni L, Guo Z, et al. 

Phrase: "Stroke 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Stroke [Disease or Syndrome]

Phrase: ";27"

Phrase: ":"

Phrase: "22305."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhu L,"

Phrase: "Fratiglioni L,"

Phrase: "Guo Z,"

Phrase: "et al."
Processing 00000000.tx.275: Incidence of dementia in relation to stroke and the apolipoprotein E 4 allele in the very old: findings from a population-based longitudinal study. 

Phrase: "Incidence of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021149:Incidence [Quantitative Concept]
   790   C0220856:incidence [Functional Concept]
   718 E C1551358:incident [Idea or Concept]

Phrase: "in relation to"

Phrase: "stroke"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "and"

Phrase: "the apolipoprotein E 4 allele in the very old"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   742   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "findings from a population-based longitudinal study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   774   C0683954:study findings [Finding]
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]
Processing 00000000.tx.276: Stroke 2000;31:7515.[Abstract/Free FullText] Forette F, Seux ML, Staessen JA, et al. 

Phrase: "Stroke 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Stroke [Disease or Syndrome]

Phrase: ";31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "7515."

Phrase: "[Abstract/Free FullText"

Phrase: "] Forette F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Seux ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Staessen JA,"

Phrase: "et al."
Processing 00000000.tx.277: Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. 

Phrase: "Prevention of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0199176:Prevention [Therapeutic or Preventive Procedure]
   790   C1706420:PREVENTION [Research Activity]
   790   C2700409:prevention [Qualitative Concept]

Phrase: "in randomised double-blind placebo-controlled systolic hypertension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0221155:Systolic hypertension [Disease or Syndrome]
   795   C0020538:Hypertension [Disease or Syndrome]
   795   C0039155:Systolic [Temporal Concept]
   795   C1963138:Hypertension [Finding]

Phrase: "in Europe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]

Phrase: "(Syst-Eur) trial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008976:Trial [Research Activity]
Processing 00000000.tx.278: Lancet 1998;352:134751.[ISI][Medline] Corder EH, Saunders AM, Risch NJ, et al. 

Phrase: "Lancet 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ";352"

Phrase: ":"

Phrase: "134751."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corder EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Saunders"

Phrase: "AM"

Phrase: ","

Phrase: "Risch NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.279: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. 

Phrase: "Protective effect of apolipoprotein E type 2 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "for late onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.280: Nat Genet 1994;4:1804. 

Phrase: "Nat Genet 1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ";4"

Phrase: ":"

Phrase: "1804."
Processing 00000000.tx.281: Guo Z, Viitanen M, Fratiglioni L, et al. 

Phrase: "Guo Z,"

Phrase: "Viitanen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fratiglioni L,"

Phrase: "et al."
Processing 00000000.tx.282: Low blood pressure and dementia in elderly people: the Kungsholmen project. 

Phrase: "Low blood pressure"
Meta Candidates (Total=20; Excluded=7; Pruned=0; Remaining=13)
  1000   C0020649:Blood Pressure, Low [Finding]
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0205251:low [Qualitative Concept]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1299352:Low [Qualitative Concept]
   827   C1306345:Pressure [Functional Concept]
   827   C1550472:low [Idea or Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "dementia in elderly people"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "the Kungsholmen project."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709701:Project [Conceptual Entity]
Processing 00000000.tx.283: BMJ 1996;312:8058.[Abstract/Free FullText] Received for publication July 8, 1999. 

Phrase: "BMJ 1996"

Phrase: ";312"

Phrase: ":"

Phrase: "8058."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Received for publication July 8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "1999."
Processing 00000000.tx.284: Accepted for publication March 31, 2000.

Phrase: "Accepted for publication March 31,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C0450355:31 [Intellectual Product]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2000."

